| 1 | L - Antineoplastic and immunomodulating agents | - | - | - | - | [1] 85 85 💬
|
| 2 | L 44 | - | - | - | - | [1] 96 96 💬
|
| 3 | L acetyl carnitine | - | - | - | - | [1] 13 13 💬
|
| 4 | L-000124467 | - | - | - | - | [2] 13 13, 46 💬
|
| 5 | L-000124467 (freebase) | - | - | - | - | [1] 46 46 💬
|
| 6 | L-000124467-009J (succinat | - | - | - | - | [1] 46 46 💬
|
| 7 | L-000883191 | - | - | - | - | [1] 46 46 💬
|
| 8 | L-001069957 | - | - | - | - | [1] 46 46 💬
|
| 9 | L-123 Ioflupane | - | - | - | - | [1] 6 6 💬
|
| 10 | L-3-(3,4-Dihydroxyphenyl)alanine | [1] Alanine Alanine | [1] Alanine
Alanine
💬
| - | - | [1] 6 6 💬
|
| 11 | L-883191 | - | - | - | - | [1] 46 46 💬
|
| 12 | L-AA | - | - | - | - | [1] 240 240 💬
|
| 13 | L-alanine | [1] Alanine Alanine | [1] Alanine
Alanine
💬
| - | - | [1] 299 299 💬
|
| 14 | L-Arginin-hydrochlorid-einmolar Fresenius | - | - | - | - | [1] 65 65 💬
|
| 15 | L-arginine | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [10] 2 2, 21, 46, 67, 96, 97, 98, 113, 223, 299 💬
|
| 16 | L-Carnitine | - | - | - | - | [5] 13 13, 46, 86, 96, 240 💬
|
| 17 | L-Carnitine Injection,1000mg once daily | - | - | - | - | [1] 2 2 💬
|
| 18 | L-Citrulline | [1] Citrulline Citrulline | [2] L-Citrulline
L-Citrulline
,
Citrulline malate
💬
| - | - | [1] 21 21 💬
|
| 19 | L-Citrulline and Metformin & L-Citrulline | [2] Citrulline Citrulline, Metformin | [4] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
,
L-Citrulline
,
Citrulline malate
💬
| [2] PRKAA1 PRKAA1, PRKAA2 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 113 113 💬
|
| 20 | L-Citrulline Malate | [1] Citrulline Citrulline | [2] L-Citrulline
L-Citrulline
,
Citrulline malate
💬
| - | - | [1] 86 86 💬
|
| 21 | L-CsA | - | - | - | - | [1] 228 228 💬
|
| 22 | L-DOPA | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 23 | L-Dopa/ MODOPAR | - | - | - | - | [1] 6 6 💬
|
| 24 | L-DOPA/DDCI | - | - | - | - | [1] 6 6 💬
|
| 25 | L-DOPS | - | - | - | - | [1] 6 6 💬
|
| 26 | L-fucose | [1] Fucose Fucose | [1] Elfucose
Elfucose
💬
| - | - | [2] 65 65, 248 💬
|
| 27 | L-Glutamine | [1] L-Glutamine L-Glutamine | [1] Glutamine
Glutamine
💬
| - | - | [2] 113 113, 299 💬
|
| 28 | L-Histidine | [1] Histidine Histidine | [1] Histidine
Histidine
💬
| - | - | [1] 13 13 💬
|
| 29 | L-Lactic acid | [2] L-Lactic acid L-Lactic acid, Lactic acid | [2] Lactic acid
Lactic acid
,
Sodium lactate
💬
| - | - | [1] 265 265 💬
|
| 30 | L-leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [1] 284 284 💬
|
| 31 | L-Lysine N acetylcysteinate | [1] Lysine Lysine | [4] Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 299 299 💬
|
| 32 | L-Lysine N-acetylcysteinate | [1] Lysine Lysine | [4] Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 299 299 💬
|
| 33 | L-Lysine- N-acetylcysteinate | [1] Lysine Lysine | [4] Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 299 299 💬
|
| 34 | L-Lysine-N-acetyl-L-cysteinate | [1] Lysine Lysine | [4] Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 299 299 💬
|
| 35 | L-Lysine-N-acetylcysteinate | [1] Lysine Lysine | [4] Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 299 299 💬
|
| 36 | L-Lysyl-D-Prolyl-L-Threonine Acetate | [2] Acetate Acetate, Threonine | [1] Threonine
Threonine
💬
| - | - | [1] 97 97 💬
|
| 37 | L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate | [1] Acetate Acetate | - | - | - | [1] 97 97 💬
|
| 38 | L-methionine | [1] Methionine Methionine | [1] Methionine
Methionine
💬
| - | - | [1] 84 84 💬
|
| 39 | L-METHIONINE ([11C]METHYL) | [1] Methionine Methionine | [1] Methionine
Methionine
💬
| - | - | [1] 84 84 💬
|
| 40 | L-Serine | [1] Serine Serine | [1] Serine
Serine
💬
| - | - | [1] 2 2 💬
|
| 41 | L-Threo DOPS | - | - | - | - | [1] 17 17 💬
|
| 42 | L-tyrosine | [1] Tyrosine Tyrosine | [1] Tyrosine
Tyrosine
💬
| - | - | [2] 6 6, 111 💬
|
| 43 | L0006CP03A | - | - | - | - | [1] 75 75 💬
|
| 44 | L01 - Antineoplastic agents | - | - | - | - | [1] 85 85 💬
|
| 45 | L0122 | - | - | - | - | [1] 279 279 💬
|
| 46 | L0133 | - | - | - | - | [1] 50 50 💬
|
| 47 | L01AA03 | - | - | - | - | [1] 28 28 💬
|
| 48 | L01BA | - | - | - | - | [1] 96 96 💬
|
| 49 | L01BA01 | - | - | - | - | [2] 46 46, 107 💬
|
| 50 | L01BB04 | - | - | - | - | [1] 13 13 💬
|
| 51 | L01FC01 | - | - | - | - | [1] 63 63 💬
|
| 52 | L01X - Other antineoplastic agents | - | - | - | - | [1] 85 85 💬
|
| 53 | L01X CO2 | - | - | - | - | [1] 46 46 💬
|
| 54 | L01XC02 | - | - | - | - | [1] 46 46 💬
|
| 55 | L01XE - Protein kinase inhibitors | - | - | - | - | [1] 85 85 💬
|
| 56 | L01XE01 | - | - | - | - | [1] 86 86 💬
|
| 57 | L01XE31 - Nintedanib | [1] Nintedanib Nintedanib | [2] Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| [36] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 💬
|
| 58 | L03 AB | - | - | - | - | [1] 13 13 💬
|
| 59 | L03 AB 08 | - | - | - | - | [1] 13 13 💬
|
| 60 | L03 AB07 | - | - | - | - | [1] 13 13 💬
|
| 61 | L03AB13 | - | - | - | - | [1] 13 13 💬
|
| 62 | L04 AB04 | - | - | - | - | [1] 46 46 💬
|
| 63 | L04041) | - | - | - | - | [1] 46 46 💬
|
| 64 | L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE | - | - | - | - | [1] 13 13 💬
|
| 65 | L04AA10 | - | - | - | - | [2] 278 278, 280 💬
|
| 66 | L04AA11 | - | - | - | - | [1] 46 46 💬
|
| 67 | L04AA18 | - | - | - | - | [1] 158 158 💬
|
| 68 | L04AA24 | - | - | - | - | [2] 46 46, 271 💬
|
| 69 | L04AA25 | - | - | - | - | [1] 62 62 💬
|
| 70 | L04AA26 | - | - | - | - | [1] 49 49 💬
|
| 71 | L04AA31 | - | - | - | - | [1] 13 13 💬
|
| 72 | L04AB0 | - | - | - | - | [2] 46 46, 271 💬
|
| 73 | L04AB01 | - | - | - | - | [2] 46 46, 271 💬
|
| 74 | L04AB04 | - | - | - | - | [5] 46 46, 96, 107, 160, 271 💬
|
| 75 | L04AB05 | - | - | - | - | [2] 46 46, 271 💬
|
| 76 | L04AC06 | - | - | - | - | [2] 44 44, 45 💬
|
| 77 | L04AC07 | - | - | - | - | [2] 41 41, 46 💬
|
| 78 | L04AX01 | - | - | - | - | [1] 96 96 💬
|
| 79 | L04AX03 | - | - | - | - | [1] 46 46 💬
|
| 80 | L2-01 adipose-derived mesenchymal stem cells (MSC) | - | - | - | - | [1] 96 96 💬
|
| 81 | L606 (Liposomal Treprostinil) Inhalation Solution 51ug | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 82 | L606 Inhalation System | - | - | - | - | [1] 86 86 💬
|
| 83 | L608 Inhalation Solution | - | - | - | - | [1] 86 86 💬
|
| 84 | L608 Liposomal inhalation suspension | - | - | - | - | [1] 86 86 💬
|
| 85 | LA294 | - | - | - | - | [1] 49 49 💬
|
| 86 | LABA/LAMA | - | - | - | - | [1] 299 299 💬
|
| 87 | Lacosamide | [1] Lacosamide Lacosamide | [1] Lacosamide
Lacosamide
💬
| [2] SCN3A SCN3A, SCN9A 💬
| [1] Taste transduction Taste transduction 💬 | [4] 2 2, 46, 149, 298 💬
|
| 88 | Lacripep | [1] Lacripep Lacripep | - | - | - | [1] 53 53 💬
|
| 89 | Lacryvisc | - | - | - | - | [1] 53 53 💬
|
| 90 | Lactated Ringer | - | - | - | - | [1] 296 296 💬
|
| 91 | Lactated Ringers | - | - | - | - | [2] 96 96, 97 💬
|
| 92 | Lacteol forte capsules | - | - | - | - | [1] 49 49 💬
|
| 93 | Lactibane Iki | - | - | - | - | [1] 13 13 💬
|
| 94 | Lactic acid | [1] Lactic acid Lactic acid | [2] Lactic acid
Lactic acid
,
Sodium lactate
💬
| - | - | [3] 46 46, 265, 299 💬
|
| 95 | Lactic acid producing organisms | [1] Lactic acid Lactic acid | [2] Lactic acid
Lactic acid
,
Sodium lactate
💬
| - | - | [1] 299 299 💬
|
| 96 | Lactizole nebulization | - | - | - | - | [1] 299 299 💬
|
| 97 | Lactobacillus | - | - | - | - | [1] 51 51 💬
|
| 98 | Lactobacillus acidophilus | [1] Lactobacillus acidophilus Lactobacillus acidophilus | [1] Lactomin
Lactomin
💬
| - | - | [1] 6 6 💬
|
| 99 | Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers | [1] Lactobacillus acidophilus Lactobacillus acidophilus | [1] Lactomin
Lactomin
💬
| - | - | [1] 6 6 💬
|
| 100 | Lactobacillus casei | [1] Lactobacillus casei Lactobacillus casei | [1] Lactobacillus casei
Lactobacillus casei
💬
| - | - | [3] 6 6, 97, 296 💬
|
| 101 | Lactobacillus casei DG | [1] Lactobacillus casei Lactobacillus casei | [1] Lactobacillus casei
Lactobacillus casei
💬
| - | - | [1] 97 97 💬
|
| 102 | Lactobacillus casei DG (Enterolactis duo®) | [1] Lactobacillus casei Lactobacillus casei | [1] Lactobacillus casei
Lactobacillus casei
💬
| - | - | [1] 6 6 💬
|
| 103 | Lactobacillus casei rhamnosus (Lcr35) | [1] Lactobacillus casei Lactobacillus casei | [1] Lactobacillus casei
Lactobacillus casei
💬
| - | - | [1] 296 296 💬
|
| 104 | Lactobacillus GG | - | - | - | - | [1] 97 97 💬
|
| 105 | Lactobacillus paracasei | [1] Lactobacillus paracasei Lactobacillus paracasei | - | - | - | [1] 79 79 💬
|
| 106 | Lactobacillus paracasei B21060 | [1] Lactobacillus paracasei Lactobacillus paracasei | - | - | - | [1] 79 79 💬
|
| 107 | Lactobacillus plantarum | [1] Lactobacillus plantarum Lactobacillus plantarum | - | - | - | [3] 6 6, 97, 156 💬
|
| 108 | Lactobacillus plantarum PS128 | [1] Lactobacillus plantarum Lactobacillus plantarum | - | - | - | [1] 6 6 💬
|
| 109 | LACTOBACILLUS REUTERI | [1] Lactobacillus reuteri Lactobacillus reuteri | - | - | - | [2] 97 97, 299 💬
|
| 110 | Lactobacillus rhamnosus | - | - | - | - | [1] 299 299 💬
|
| 111 | Lactobacillus rhamnosus CALM 607(LR607) | - | - | - | - | [1] 97 97 💬
|
| 112 | Lactobacillus Rhamnosus GG | - | - | - | - | [2] 13 13, 299 💬
|
| 113 | Lactobacillus rhamnosus GG ATCC 53103 | - | - | - | - | [1] 97 97 💬
|
| 114 | Lactobacillus salivarius UCC118 | - | - | - | - | [2] 96 96, 97 💬
|
| 115 | Lactobacilus acidophilus & bifidobacterium animalis/lactis | - | - | - | - | [1] 97 97 💬
|
| 116 | Lactoferrin | [1] Lactoferrin Lactoferrin | - | - | - | [1] 97 97 💬
|
| 117 | Lactose | [1] Lactose Lactose | [2] Anhydrous lactose
Anhydrous lactose
,
Lactose hydrate
💬
| - | - | [8] 2 2, 6, 13, 21, 97, 107, 228, 310 💬
|
| 118 | Lactose in water | [2] Lactose Lactose, Water | [3] Water
Water
,
Anhydrous lactose
,
Lactose hydrate
💬
| - | - | [1] 97 97 💬
|
| 119 | Lactose monohydrate | [1] Lactose Lactose | [2] Anhydrous lactose
Anhydrous lactose
,
Lactose hydrate
💬
| - | - | [1] 13 13 💬
|
| 120 | Lactose Sachet | [1] Lactose Lactose | [2] Anhydrous lactose
Anhydrous lactose
,
Lactose hydrate
💬
| - | - | [1] 97 97 💬
|
| 121 | Lactulose | [1] Lactulose Lactulose | [1] Lactulose
Lactulose
💬
| - | - | [5] 6 6, 13, 96, 97, 291 💬
|
| 122 | Lactulose/Rhamnose solution | [2] Lactulose Lactulose, Rhamnose | [1] Lactulose
Lactulose
💬
| - | - | [1] 96 96 💬
|
| 123 | Ladarixin | [1] Ladarixin Ladarixin | - | - | - | [1] 162 162 💬
|
| 124 | Lademirsen | [1] Lademirsen Lademirsen | - | - | - | [1] 218 218 💬
|
| 125 | Lademirsen (SAR339375) | [1] Lademirsen Lademirsen | - | - | - | [1] 218 218 💬
|
| 126 | LADICell | - | - | - | - | [1] 65 65 💬
|
| 127 | LAM-001 | - | - | - | - | [1] 228 228 💬
|
| 128 | LAM-002A | - | - | - | - | [1] 2 2 💬
|
| 129 | LAMAZYM | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬
| [1] MAN2B1 MAN2B1 💬
| [2] Lysosome biogenesis Lysosome biogenesis, Other glycan degradation 💬 | [1] 19 19 💬
|
| 130 | Lamictal | - | - | - | - | [1] 144 144 💬
|
| 131 | Lamivudine | [1] Lamivudine Lamivudine | [1] Lamivudine
Lamivudine
💬
| - | - | [10] 2 2, 26, 42, 46, 49, 135, 156, 223, 265, 325 💬
|
| 132 | Lamivudine (3TC) | [1] Lamivudine Lamivudine | [1] Lamivudine
Lamivudine
💬
| - | - | [1] 325 325 💬
|
| 133 | Lamivudine/Zidovudine | [2] Lamivudine Lamivudine, Zidovudine | [2] Lamivudine
Lamivudine
,
Zidovudine
💬
| - | - | [1] 265 265 💬
|
| 134 | Lamotrigin | - | - | - | - | [2] 34 34, 195 💬
|
| 135 | Lamotrigin actavis | - | - | - | - | [3] 113 113, 114, 115 💬
|
| 136 | Lamotrigin beta | - | - | - | - | [2] 34 34, 195 💬
|
| 137 | Lamotrigin ”Nordic Prime 100 mg | - | - | - | - | [2] 114 114, 115 💬
|
| 138 | Lamotrigin ”Nordic Prime 25 mg | - | - | - | - | [2] 114 114, 115 💬
|
| 139 | Lamotrigin ”Nordic Prime 50 mg | - | - | - | - | [2] 114 114, 115 💬
|
| 140 | Lamotrigine | [1] Lamotrigine Lamotrigine | [1] Lamotrigine
Lamotrigine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [7] 13 13, 34, 38, 113, 114, 115, 144 💬
|
| 141 | Lamotrigine - generic product | [1] Lamotrigine Lamotrigine | [1] Lamotrigine
Lamotrigine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 38 38 💬
|
| 142 | Lamotrigine 25Mg Oral Tablet, Extended Release | [1] Lamotrigine Lamotrigine | [1] Lamotrigine
Lamotrigine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 114 114 💬
|
| 143 | Lamotrigine dispers | [1] Lamotrigine Lamotrigine | [1] Lamotrigine
Lamotrigine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 34 34 💬
|
| 144 | Lamotrigine extended release tablets | [1] Lamotrigine Lamotrigine | [1] Lamotrigine
Lamotrigine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 13 13 💬
|
| 145 | LANADELUMAB | [1] Lanadelumab Lanadelumab | [1] Lanadelumab
Lanadelumab
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 146 | Lanadelumab 150 mg | [1] Lanadelumab Lanadelumab | [1] Lanadelumab
Lanadelumab
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 147 | Lanadelumab 300 mg | [1] Lanadelumab Lanadelumab | [1] Lanadelumab
Lanadelumab
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 148 | Land exercises | - | - | - | - | [1] 46 46 💬
|
| 149 | Landmark-based intrathecal administration of nusinersen | [1] Nusinersen Nusinersen | [2] Nusinersen sodium
Nusinersen sodium
,
Nusinersen
💬
| - | - | [1] 3 3 💬
|
| 150 | LANIFIBRANOR | [1] Lanifibranor Lanifibranor | [1] Lanifibranor
Lanifibranor
💬
| [3] PPARA PPARA, PPARD, PPARG 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 151 | Lanraplenib | [1] Lanraplenib Lanraplenib | [1] Lanraplenib
Lanraplenib
💬
| - | - | [2] 53 53, 222 💬
|
| 152 | LANREOTIDA | - | - | - | - | [1] 77 77 💬
|
| 153 | Lanreotida Autogel 120 mg | - | - | - | - | [1] 77 77 💬
|
| 154 | Lanreotide | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [5] 67 67, 73, 77, 85, 298 💬
|
| 155 | Lanreotide (Autogel formulation) | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 156 | Lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose interval | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 157 | Lanreotide (Autogel formulation), duration of treatment 46-48 weeks | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 158 | Lanreotide 60Mg Solution for Injection | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 159 | LANREOTIDE ACETATE | [2] Acetate Acetate, Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [4] 67 67, 77, 85, 298 💬
|
| 160 | LANREOTIDE ACETATO | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 161 | Lanreotide ATG | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 162 | Lanreotide ATG 120mg | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 163 | Lanreotide autogel | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 164 | Lanreotide Autogel 120 mg | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 165 | Lanreotide Autogel 120mg | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 166 | Lanreotide Autogel and Octreotide LAR | [2] Lanreotide Lanreotide, Octreotide | [6] Octreotide
Octreotide
,
Octreotide acetate
,
Lanreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 167 | Lanreotide Autogel® | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 168 | Lanreotide PRF | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 169 | Lanreotide-Autogel 120 mg | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 170 | Lansolprazole | - | - | - | - | [1] 166 166 💬
|
| 171 | Lansoprazole | [1] Lansoprazole Lansoprazole | [1] Lansoprazole
Lansoprazole
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [8] 63 63, 71, 85, 98, 166, 222, 223, 299 💬
|
| 172 | Lansoprazole 30mg | [1] Lansoprazole Lansoprazole | [1] Lansoprazole
Lansoprazole
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 166 166 💬
|
| 173 | Lansoprazole, amoxicillin, clarithromycin | [3] Amoxicillin Amoxicillin, Clarithromycin, Lansoprazole | [5] Amoxicillin
Amoxicillin
,
Clarithromycin
,
Lansoprazole
,
Amoxicillin sodium
,
Amoxicillin
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [2] 222 222, 223 💬
|
| 174 | Lansoprazole, clarithromycin, amoxycillin | [2] Clarithromycin Clarithromycin, Lansoprazole | [2] Clarithromycin
Clarithromycin
,
Lansoprazole
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 63 63 💬
|
| 175 | Lantarel | - | - | - | - | [1] 46 46 💬
|
| 176 | Lantus 100 units/ml solution for injection in a cartridge | - | - | - | - | [1] 299 299 💬
|
| 177 | LANTUS*SC 5CAR3ML100UI/ML | - | - | - | - | [1] 299 299 💬
|
| 178 | Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen | - | - | - | - | [1] 299 299 💬
|
| 179 | Lap TAP Bupivacaine/Epinephrine | [2] Bupivacaine Bupivacaine, Epinephrine | [5] Epinephrine
Epinephrine
,
Epinephrine hydrochloride
,
Bupivacaine hydrochloride
,
Epinephrine bitartrate
,
Bupivacaine
💬
| [15] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 180 | Lapaquistat | [1] Lapaquistat Lapaquistat | - | - | - | [1] 79 79 💬
|
| 181 | Lapaquistat acetate and current lipid-lowering treatment | [2] Acetate Acetate, Lapaquistat | - | - | - | [1] 79 79 💬
|
| 182 | Lapatinib | [1] Lapatinib Lapatinib | [2] Lapatinib ditosylate
Lapatinib ditosylate
,
Lapatinib
💬
| [2] EGFR EGFR, ERBB2 💬
| [50] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, Virion - Hepatitis viruses 💬 | [3] 34 34, 74, 75 💬
|
| 183 | Lapine T-Lymphocyte Immune Globulin | - | - | - | - | [4] 62 62, 65, 284, 286 💬
|
| 184 | LAQUINIMOD | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [4] 8 8, 13, 49, 96 💬
|
| 185 | Laquinimod 0.3 | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 13 13 💬
|
| 186 | Laquinimod 0.6 | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 13 13 💬
|
| 187 | Laquinimod 1.2 | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 13 13 💬
|
| 188 | Laquinimod Capsulas 0.6 mg | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 13 13 💬
|
| 189 | Laquinimod Capsules 0.3 mg | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 13 13 💬
|
| 190 | Laquinimod capsules 0.5 mg | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [2] 8 8, 96 💬
|
| 191 | Laquinimod Capsules 0.6 mg | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 13 13 💬
|
| 192 | Laquinimod Cápsulas 0.5 mg | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 96 96 💬
|
| 193 | Laquinimod Sodium (USAN) | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 13 13 💬
|
| 194 | Laquinimod Tablets 0.3 mg | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 13 13 💬
|
| 195 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | [4] Dapsone Dapsone, Mycophenolate mofetil, Prednisolone, Triamcinolone | [8] Triamcinolone
Triamcinolone
,
Prednisolone
,
Dapsone
,
Mycophenolate mofetil
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
,
Mycophenolate mofetil hydrochloride
💬
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬
| [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 162 162 💬
|
| 196 | Large Neutral Amino Acid Therapy | - | - | - | - | [1] 240 240 💬
|
| 197 | Large protein molecule | - | - | - | - | [1] 46 46 💬
|
| 198 | Lariam | - | - | - | - | [1] 25 25 💬
|
| 199 | LARONIDASE | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [2] 19 19, 256 💬
|
| 200 | Laronidase ERT | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 201 | Laronidase therapy and a stem cell transplant | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 202 | Laropiprant | [1] Laropiprant Laropiprant | [1] Laropiprant
Laropiprant
💬
| [1] PTGDR PTGDR 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 79 79 💬
|
| 203 | Laser doppler vibrometry (LDV), heart(cordium) carotid pulse wave velocity (ccPWV) | - | - | - | - | [1] 167 167 💬
|
| 204 | Late biologic therapy | - | - | - | - | [1] 96 96 💬
|
| 205 | Latozinemab | [1] Latozinemab Latozinemab | [1] Latozinemab
Latozinemab
💬
| [1] SORT1 SORT1 💬
| [3] Cholesterol metabolism Cholesterol metabolism, Lysosome biogenesis, Neurotrophin signaling pathway 💬 | [1] 127 127 💬
|
| 206 | Latrepirdine | [1] Latrepirdine Latrepirdine | [2] Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| [6] ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 💬
|
| 207 | LAU-7b | - | - | - | - | [1] 299 299 💬
|
| 208 | Lavender oil | [1] Lavender oil Lavender oil | [1] Lavender oil
Lavender oil
💬
| - | - | [1] 13 13 💬
|
| 209 | LAX-101 | [1] LAX-101 LAX-101 | - | - | - | [1] 8 8 💬
|
| 210 | Laxabon | - | - | - | - | [1] 96 96 💬
|
| 211 | LB-P6 | - | - | - | - | [1] 46 46 💬
|
| 212 | LB-P8 | [1] LB-P8 LB-P8 | - | - | - | [2] 46 46, 94 💬
|
| 213 | LB-P8 high-dose | [1] LB-P8 LB-P8 | - | - | - | [1] 94 94 💬
|
| 214 | LB-P8 low-dose | [1] LB-P8 LB-P8 | - | - | - | [1] 94 94 💬
|
| 215 | LBAL | - | - | - | - | [1] 46 46 💬
|
| 216 | LBEC0101 | - | - | - | - | [1] 46 46 💬
|
| 217 | LBL-047 for Injection | - | - | - | - | [1] 49 49 💬
|
| 218 | LBS-008, BPN-14967 | - | - | - | - | [1] 301 301 💬
|
| 219 | LBT-3627 | - | - | - | - | [1] 6 6 💬
|
| 220 | LC51-0255 | - | - | - | - | [1] 97 97 💬
|
| 221 | LCAR-AIO T cells | - | - | - | - | [3] 11 11, 13, 49 💬
|
| 222 | LCI699 | - | - | - | - | [1] 75 75 💬
|
| 223 | LCI699, 1 mg | - | - | - | - | [1] 75 75 💬
|
| 224 | LCI699, 10 mg | - | - | - | - | [1] 75 75 💬
|
| 225 | LCI699, 20 mg | - | - | - | - | [1] 75 75 💬
|
| 226 | LCI699, 5 mg | - | - | - | - | [1] 75 75 💬
|
| 227 | LCIG | - | - | - | - | [1] 6 6 💬
|
| 228 | LCIG (Duodopa) | - | - | - | - | [1] 6 6 💬
|
| 229 | LCP-Tacro (tacrolimus) | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 95 95 💬
|
| 230 | LCZ696 | - | - | - | - | [1] 58 58 💬
|
| 231 | LCZ696 100 mg | - | - | - | - | [1] 58 58 💬
|
| 232 | LCZ696 200 mg | - | - | - | - | [1] 58 58 💬
|
| 233 | LCZ696 50 mg | - | - | - | - | [1] 58 58 💬
|
| 234 | LD / BE | - | - | - | - | [1] 6 6 💬
|
| 235 | LD and GC012F CAR-T Cell Injection | [1] GC012F GC012F | - | - | - | [1] 46 46 💬
|
| 236 | LD+DDCI | - | - | - | - | [1] 6 6 💬
|
| 237 | LD-aminopterin | [1] Aminopterin Aminopterin | [1] Aminopterin sodium
Aminopterin sodium
💬
| - | - | [1] 46 46 💬
|
| 238 | LD-DDCI | - | - | - | - | [1] 6 6 💬
|
| 239 | LD/CD | - | - | - | - | [1] 6 6 💬
|
| 240 | LD/CD SC solution | - | - | - | - | [1] 6 6 💬
|
| 241 | LDP-02 | - | - | - | - | [2] 96 96, 97 💬
|
| 242 | LE051 | - | - | - | - | [1] 113 113 💬
|
| 243 | Lead Candidate | - | - | - | - | [1] 5 5 💬
|
| 244 | LEBRIKIZUMAB | [1] Lebrikizumab Lebrikizumab | [1] Lebrikizumab
Lebrikizumab
💬
| [1] IL13 IL13 💬
| [8] Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | [1] 85 85 💬
|
| 245 | Lecanemab | [1] Lecanemab Lecanemab | [1] Lecanemab
Lecanemab
💬
| [1] APP APP 💬
| [4] Alzheimer disease Alzheimer disease, IgSF CAM signaling, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse 💬 | [1] 6 6 💬
|
| 246 | LECIG (levodopa, carbidopa, entacapone intestinal gel) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 247 | Lecithin | [1] Lecithin Lecithin | [1] Lecithin
Lecithin
💬
| - | - | [1] 340 340 💬
|
| 248 | Lederspan | - | - | - | - | [1] 107 107 💬
|
| 249 | Ledertrexate | - | - | - | - | [1] 46 46 💬
|
| 250 | Ledertrexato | - | - | - | - | [1] 46 46 💬
|
| 251 | Ledertrexato 2,5 mg comprimés | - | - | - | - | [1] 46 46 💬
|
| 252 | Ledipasvir | [1] Ledipasvir Ledipasvir | [1] Ledipasvir
Ledipasvir
💬
| - | - | [1] 19 19 💬
|
| 253 | Ledipasvir/Sofosbuvir | [2] Ledipasvir Ledipasvir, Sofosbuvir | [2] Sofosbuvir
Sofosbuvir
,
Ledipasvir
💬
| - | - | [1] 19 19 💬
|
| 254 | Lefamulin | [1] Lefamulin Lefamulin | [2] Lefamulin
Lefamulin
,
Lefamulin acetate
💬
| - | - | [1] 299 299 💬
|
| 255 | Leflunomide | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [14] 11 11, 40, 46, 49, 53, 54, 66, 107, 162, 223, 224, 270, 271, 300 💬
|
| 256 | Leflunomide (permitted, not necessary) | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [1] 46 46 💬
|
| 257 | Leflunomide 10 milligram (MG) | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [1] 46 46 💬
|
| 258 | Leflunomide 20 mg Tablets (Geneva Pharmaceutical) | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [1] 46 46 💬
|
| 259 | Leflunomide 20 mg+prednisone 0.5mg/kg/d | [2] Leflunomide Leflunomide, Prednisone | [2] Prednisone
Prednisone
,
Leflunomide
💬
| [2] DHODH DHODH, NR3C1 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬 | [2] 66 66, 223 💬
|
| 260 | Leflunomide 20Mg Tab | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [1] 46 46 💬
|
| 261 | Leflunomide 20mg/d | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [1] 53 53 💬
|
| 262 | Leflunomide Mylan | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [1] 53 53 💬
|
| 263 | Leflunomide plus Methotrexate | [2] Leflunomide Leflunomide, Methotrexate | [3] Methotrexate
Methotrexate
,
Leflunomide
,
Methotrexate sodium
💬
| [3] DHFR DHFR, DHFR2, DHODH 💬
| [4] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate, Pyrimidine metabolism 💬 | [1] 107 107 💬
|
| 264 | Leflunomide(LEF) | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [2] 40 40, 224 💬
|
| 265 | Leflunomide-Sulfasalazine-Hydroxychloroquine | [3] Hydroxychloroquine Hydroxychloroquine, Leflunomide, Sulfasalazine | [4] Sulfasalazine
Sulfasalazine
,
Leflunomide
,
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [1] 46 46 💬
|
| 266 | Leflunomidum | - | - | - | - | [1] 46 46 💬
|
| 267 | Lemborexant | [1] Lemborexant Lemborexant | [1] Lemborexant
Lemborexant
💬
| [2] HCRTR1 HCRTR1, HCRTR2 💬
| [2] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [2] 6 6, 127 💬
|
| 268 | Lemborexant 5 MG | [1] Lemborexant Lemborexant | [1] Lemborexant
Lemborexant
💬
| [2] HCRTR1 HCRTR1, HCRTR2 💬
| [2] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 127 127 💬
|
| 269 | Lemtrada | - | - | - | - | [2] 13 13, 65 💬
|
| 270 | LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung | - | - | - | - | [1] 13 13 💬
|
| 271 | Lenabasum | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 50 50, 51, 299 💬
|
| 272 | Lenabasum 20 mg | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 51 51, 299 💬
|
| 273 | Lenabasum 20 mg Powder in Capsule | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 274 | Lenabasum 5 mg | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 51 51, 299 💬
|
| 275 | Lenabasum 5 mg Powder in Capsule | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 276 | Lenabasum 5mg Powder in Capsule | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 277 | Lenadogene nolparvovec | [1] Lenadogene nolparvovec Lenadogene nolparvovec | - | - | - | [1] 302 302 💬
|
| 278 | Lenalidomide | [1] Lenalidomide Lenalidomide | [1] Lenalidomide
Lenalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [9] 16 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
|
| 279 | Lenalidomide 10 mg | [1] Lenalidomide Lenalidomide | [1] Lenalidomide
Lenalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 56 56 💬
|
| 280 | Lenalidomide 25mg | [1] Lenalidomide Lenalidomide | [1] Lenalidomide
Lenalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 💬
|
| 281 | Lenalidomide and dexamethasone | [2] Dexamethasone Dexamethasone, Lenalidomide | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Lenalidomide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 16 16 💬
|
| 282 | Lenalidomide+Dexamethasone | [2] Dexamethasone Dexamethasone, Lenalidomide | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Lenalidomide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 16 16 💬
|
| 283 | Lenalidomide, Dexamethasone | [2] Dexamethasone Dexamethasone, Lenalidomide | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Lenalidomide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 16 16 💬
|
| 284 | Lenalidomide, Dexamethasone and Cyclophosphamide | [3] Cyclophosphamide Cyclophosphamide, Dexamethasone, Lenalidomide | [6] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
,
Lenalidomide
,
Cyclophosphamide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, TNF 💬
| [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 💬
|
| 285 | Leniolisib | [1] Leniolisib Leniolisib | [2] Leniolisib
Leniolisib
,
Leniolisib phosphate
💬
| [3] PIK3CA PIK3CA, PIK3CB, PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [2] 53 53, 65 💬
|
| 286 | Leniolisib phosphate | [1] Leniolisib Leniolisib | [2] Leniolisib
Leniolisib
,
Leniolisib phosphate
💬
| [3] PIK3CA PIK3CA, PIK3CB, PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 65 65 💬
|
| 287 | Lenogastrim | - | - | - | - | [1] 28 28 💬
|
| 288 | Lenograstim | [1] Lenograstim Lenograstim | [1] Lenograstim
Lenograstim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [8] 2 2, 13, 16, 18, 19, 57, 65, 97 💬
|
| 289 | Lenrispodun | [1] Lenrispodun Lenrispodun | [1] Lenrispodun
Lenrispodun
💬
| [3] PDE1A PDE1A, PDE1B, PDE1C 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Morphine addiction, Olfactory transduction, Purine metabolism, Renin secretion, Taste transduction 💬 | [1] 6 6 💬
|
| 290 | Lenti-D Drug Product | - | - | - | - | [1] 20 20 💬
|
| 291 | Lentiviral G1XCGD Gene Therapy | - | - | - | - | [1] 65 65 💬
|
| 292 | Lentiviral vector containing ABCA4 gene | - | - | - | - | [1] 301 301 💬
|
| 293 | Lentiviral vector containing MYO7A gene | - | - | - | - | [2] 90 90, 303 💬
|
| 294 | Lentiviral vector containing the ABCA4 gene | - | - | - | - | [1] 301 301 💬
|
| 295 | Lentiviral vector containing the human MY07A gene | - | - | - | - | [2] 90 90, 303 💬
|
| 296 | Lentiviral Vector Trans-Skip gene modified Autologous Mesoangioblasts | - | - | - | - | [1] 113 113 💬
|
| 297 | Lentiviral vector transduced CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 298 | Lentivirus Alpha-gal A transduced stem cells | - | - | - | - | [1] 19 19 💬
|
| 299 | Lenzumestrocel | [1] Lenzumestrocel Lenzumestrocel | - | - | - | [1] 2 2 💬
|
| 300 | Leptin | [1] Leptin Leptin | - | - | - | [2] 6 6, 265 💬
|
| 301 | Lepunafusp alfa | [1] Lepunafusp alfa Lepunafusp alfa | - | - | - | [1] 19 19 💬
|
| 302 | Leqvio | - | - | - | - | [1] 79 79 💬
|
| 303 | Leqvio 284 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 79 79 💬
|
| 304 | Leramistat | - | - | - | - | [1] 85 85 💬
|
| 305 | Leriglitazone | [1] Leriglitazone Leriglitazone | [1] Leriglitazone
Leriglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 20 20 💬
|
| 306 | Lerodalcibep | [1] Lerodalcibep Lerodalcibep | [1] Lerodalcibep
Lerodalcibep
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 307 | Lerodalcibep 300 mg Monthly SC | [1] Lerodalcibep Lerodalcibep | [1] Lerodalcibep
Lerodalcibep
💬
| [1] PCSK9 PCSK9 💬
| [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 💬
|
| 308 | Letairis | - | - | - | - | [1] 85 85 💬
|
| 309 | Letairis 10 mg | - | - | - | - | [1] 85 85 💬
|
| 310 | Letairis 5 mg | - | - | - | - | [1] 85 85 💬
|
| 311 | Letermovir | [1] Letermovir Letermovir | [1] Letermovir
Letermovir
💬
| - | - | [2] 60 60, 85 💬
|
| 312 | Letrozole | [1] Letrozole Letrozole | [1] Letrozole
Letrozole
💬
| [1] CYP19A1 CYP19A1 💬
| [2] Ovarian steroidogenesis Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | [2] 81 81, 89 💬
|
| 313 | Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [13] 5 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
|
| 314 | Leuco-methylthioninium bis(hydromethanesulfonate) | [1] Methylthioninium Methylthioninium | - | - | - | [1] 127 127 💬
|
| 315 | Leucovorin | [1] Leucovorin Leucovorin | [3] Leucovorin calcium
Leucovorin calcium
,
Folinic acid
,
Folinic acid calcium salt pentahydrate
💬
| - | - | [3] 13 13, 19, 46 💬
|
| 316 | Leukapheresis | - | - | - | - | [6] 49 49, 51, 85, 96, 284, 285 💬
|
| 317 | LEUKINE | - | - | - | - | [2] 28 28, 229 💬
|
| 318 | Leukopheresis | - | - | - | - | [1] 51 51 💬
|
| 319 | Leuplin DPS 11.25mg | - | - | - | - | [1] 76 76 💬
|
| 320 | Leuprolide | [1] Leuprolide Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [5] 1 1, 2, 3, 51, 76 💬
|
| 321 | Leuprolide (GnRH agonists) | [1] Leuprolide Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 322 | Leuprolide Acetate (LA) | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 323 | Leuprolide Acetate 11.25 MG/ML | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 324 | Leuprolide Acetate 3 Month Depot | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 325 | Leuprolide Acetate 45 mg | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 326 | Leuprolide acetate depot | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 327 | Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide | [1] Leuprolide Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 328 | Leuprorelin | - | - | - | - | [2] 67 67, 76 💬
|
| 329 | Leuprorelin Acetate | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [2] 1 1, 76 💬
|
| 330 | Leuprorelin Acetate 3.75mg Injection | [1] Acetate Acetate | - | - | - | [1] 76 76 💬
|
| 331 | Leuprorelin Acetate Depot 3M | [1] Acetate Acetate | - | - | - | [1] 76 76 💬
|
| 332 | Levacetylleucine | - | - | - | - | [1] 65 65 💬
|
| 333 | Levact | - | - | - | - | [1] 61 61 💬
|
| 334 | Levamidole 50mg | - | - | - | - | [1] 222 222 💬
|
| 335 | Levamisole | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [4] 60 60, 61, 62, 222 💬
|
| 336 | Levamisole 10 mg | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [1] 222 222 💬
|
| 337 | Levamisole 10mg | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [1] 222 222 💬
|
| 338 | Levamisole 25 mg | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [1] 222 222 💬
|
| 339 | Levamisole 25mg | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [1] 222 222 💬
|
| 340 | Levamisole 5 mg | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [1] 222 222 💬
|
| 341 | Levamisole 50 mg | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [1] 222 222 💬
|
| 342 | Levamisole 5mg | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [1] 222 222 💬
|
| 343 | LEVAMISOLE CHLORHYDRATE | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [1] 222 222 💬
|
| 344 | Levamisole hydrochloride | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [2] 60 60, 222 💬
|
| 345 | Levamisole+cyclosporin A+Glucocorticoids | [1] Levamisole Levamisole | [2] Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | [2] 60 60, 62 💬
|
| 346 | Levaquin | - | - | - | - | [1] 84 84 💬
|
| 347 | Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen | - | - | - | - | [1] 299 299 💬
|
| 348 | Levemir FlexPen | - | - | - | - | [1] 299 299 💬
|
| 349 | Levemir Penfill | - | - | - | - | [1] 299 299 💬
|
| 350 | Levetiracetam | [1] Levetiracetam Levetiracetam | [1] Levetiracetam
Levetiracetam
💬
| [1] SV2A SV2A 💬
| [1] ECM-receptor interaction ECM-receptor interaction 💬 | [7] 2 2, 4, 6, 13, 34, 149, 307 💬
|
| 351 | Levitra | - | - | - | - | [2] 13 13, 86 💬
|
| 352 | Levobupivacaine | [1] Levobupivacaine Levobupivacaine | [2] Levobupivacaine hydrochloride
Levobupivacaine hydrochloride
,
Levobupivacaine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 46 46 💬
|
| 353 | Levocarnil | - | - | - | - | [1] 13 13 💬
|
| 354 | LEVOCARNITINE | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [3] 3 3, 53, 97 💬
|
| 355 | Levocarnitine propyl hydrochloride | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [1] 97 97 💬
|
| 356 | LEVOCETIRIZINA DICLORIDRATO | - | - | - | - | [1] 61 61 💬
|
| 357 | Levocitirizina | - | - | - | - | [1] 61 61 💬
|
| 358 | Levodopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [8] 5 5, 6, 17, 90, 120, 140, 164, 201 💬
|
| 359 | LEVODOPA (DC.IT) (FU) | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 360 | Levodopa (delivered intravenously) | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 361 | Levodopa (drug), intraduodenal administration | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 362 | Levodopa (L-dopa) | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 363 | Levodopa (L-DOPA) + Standard care | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 364 | LEVODOPA (LD) | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 365 | Levodopa / Benserazid | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 366 | LEVODOPA / BENSERAZIDE 200 + 50 MG | [2] Benserazide Benserazide, Levodopa | [3] Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 367 | Levodopa / carbidopa solution | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 368 | Levodopa 100 mg / benserazide 25 mg | [2] Benserazide Benserazide, Levodopa | [3] Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 369 | Levodopa 100 mg A CAP | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 370 | Levodopa 125 mg A CAP | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 371 | Levodopa 150 mg A CAP | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 372 | Levodopa 75 mg A CAP | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 373 | Levodopa acute challenge | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 374 | Levodopa and carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 375 | Levodopa and decarboxylase inhibitor | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 376 | Levodopa and Domperidone | [2] Domperidone Domperidone, Levodopa | [3] Levodopa
Levodopa
,
Domperidone
,
Domperidone maleate
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 377 | Levodopa Benserazide Madopar | [2] Benserazide Benserazide, Levodopa | [3] Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 378 | Levodopa Benserazide Teva Italia | [2] Benserazide Benserazide, Levodopa | [3] Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 379 | Levodopa Carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 380 | Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 381 | Levodopa carbidopa intestinal gel (LCIG) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 382 | Levodopa CR (controlled release) | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 383 | Levodopa Cyclops | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 384 | LEVODOPA DC.IT FU | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 385 | Levodopa dispersible | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 386 | Levodopa formulation | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 387 | Levodopa infusion | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 388 | LEVODOPA INN | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 389 | Levodopa MR | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 390 | Levodopa powder for inhalation | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 391 | Levodopa tablet | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 392 | Levodopa test | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 17 17 💬
|
| 393 | Levodopa, carbidopa, entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 394 | Levodopa, carbidopa, ODM-104 | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 395 | Levodopa, decarboxylase inhibitor and COMT inhibitor | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 396 | Levodopa-4'-Monophosphate | [2] Foslevodopa Foslevodopa, Levodopa | [2] Levodopa
Levodopa
,
Foslevodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 397 | Levodopa-Carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [2] 6 6, 90 💬
|
| 398 | Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 399 | Levodopa-Carbidopa Immediate Release | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 400 | Levodopa-carbidopa Immediate Release (LC-IR) Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 401 | Levodopa-Carbidopa Intestinal Gel | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 402 | Levodopa-Carbidopa Intestinal Gel (LCIG) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 403 | Levodopa-Carbidopa Multilayer Extended Release Tablet | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 404 | Levodopa-Carbidopa XL tablet (M) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 405 | Levodopa-carbidopa-entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 406 | Levodopa/benserazide | [2] Benserazide Benserazide, Levodopa | [3] Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 407 | Levodopa/benserazide 100/25 mg | [2] Benserazide Benserazide, Levodopa | [3] Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 408 | LEVODOPA/BENZERASIDE | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 409 | Levodopa/Benzerazide | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 410 | LEVODOPA/CARBIDOPA | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [2] 6 6, 164 💬
|
| 411 | Levodopa/Carbidopa (4:1) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 201 201 💬
|
| 412 | Levodopa/Carbidopa (LD/CD) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 413 | Levodopa/Carbidopa (Sinemet) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 414 | Levodopa/carbidopa 100/25 | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 415 | Levodopa/carbidopa oral formulation A | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 416 | Levodopa/carbidopa oral formulation B | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 417 | Levodopa/Carbidopa Solution | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 418 | Levodopa/carbidopa solution for SC administration | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 419 | Levodopa/Carbidopa(200mg/50mg) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 420 | Levodopa/carbidopa/entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 421 | Levodopa/DDCI | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 422 | Levodopa/dopa decarboxylase inhibitor | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 423 | Levofloxacin | [1] Levofloxacin Levofloxacin | [2] Levofloxacin
Levofloxacin
,
Levofloxacin
💬
| - | - | [5] 46 46, 53, 63, 84, 299 💬
|
| 424 | LEVOFLOXACIN HEMIHYDRATE | [1] Levofloxacin Levofloxacin | [2] Levofloxacin
Levofloxacin
,
Levofloxacin
💬
| - | - | [1] 299 299 💬
|
| 425 | Levofloxacin Kabi | [1] Levofloxacin Levofloxacin | [2] Levofloxacin
Levofloxacin
,
Levofloxacin
💬
| - | - | [1] 299 299 💬
|
| 426 | Levofloxacin-Based H. pylori Eradication Therapy | [1] Levofloxacin Levofloxacin | [2] Levofloxacin
Levofloxacin
,
Levofloxacin
💬
| - | - | [1] 63 63 💬
|
| 427 | LEVOFOLENE 4 MG 30 CPR | - | - | - | - | [1] 13 13 💬
|
| 428 | Levoketoconazole | [1] Levoketoconazole Levoketoconazole | [1] Levoketoconazole
Levoketoconazole
💬
| [3] CYP11A1 CYP11A1, CYP11B1, CYP17A1 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | [1] 75 75 💬
|
| 429 | Levoketozonazole | - | - | - | - | [1] 75 75 💬
|
| 430 | LEVONORGESTREL | [1] Levonorgestrel Levonorgestrel | [1] Levonorgestrel
Levonorgestrel
💬
| [1] PGR PGR 💬
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1] 13 13 💬
|
| 431 | LEVOSIMENDAN | [1] Levosimendan Levosimendan | [1] Levosimendan
Levosimendan
💬
| [2] PDE3A PDE3A, PDE3B 💬
| [10] Apelin signaling pathway Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 2 2, 57 💬
|
| 432 | Levothyroxine | [1] Levothyroxine Levothyroxine | [3] Levothyroxine sodium
Levothyroxine sodium
,
Levothyroxine
,
Levothyroxine sodium
💬
| [2] THRA THRA, THRB 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [3] 49 49, 78, 80 💬
|
| 433 | Levotonine | - | - | - | - | [1] 97 97 💬
|
| 434 | LEVOVANOX | - | - | - | - | [2] 94 94, 97 💬
|
| 435 | Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 1 | [1] Aminolevulinic acid Aminolevulinic acid | [2] Aminolevulinic acid hydrochloride
Aminolevulinic acid hydrochloride
,
Aminolevulinic acid
💬
| - | - | [1] 34 34 💬
|
| 436 | Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 2 | [1] Aminolevulinic acid Aminolevulinic acid | [2] Aminolevulinic acid hydrochloride
Aminolevulinic acid hydrochloride
,
Aminolevulinic acid
💬
| - | - | [1] 34 34 💬
|
| 437 | Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 3 | [1] Aminolevulinic acid Aminolevulinic acid | [2] Aminolevulinic acid hydrochloride
Aminolevulinic acid hydrochloride
,
Aminolevulinic acid
💬
| - | - | [1] 34 34 💬
|
| 438 | LFB-IgSC | - | - | - | - | [1] 65 65 💬
|
| 439 | LFB-R603 | - | - | - | - | [1] 13 13 💬
|
| 440 | LFB-R603, TGTX1101 | - | - | - | - | [1] 13 13 💬
|
| 441 | LFD-200 | - | - | - | - | [1] 46 46 💬
|
| 442 | LFG316 | - | - | - | - | [1] 62 62 💬
|
| 443 | LGD-4665 | - | - | - | - | [1] 63 63 💬
|
| 444 | LH VIOLA Supplementation | - | - | - | - | [2] 96 96, 97 💬
|
| 445 | Liatermin | [1] Liatermin Liatermin | [1] Liatermin
Liatermin
💬
| - | - | [1] 6 6 💬
|
| 446 | Liatermin (r-metHuGDNF) | [1] Liatermin Liatermin | [1] Liatermin
Liatermin
💬
| - | - | [1] 6 6 💬
|
| 447 | LIB003 | - | - | - | - | [1] 79 79 💬
|
| 448 | Liberase Enzyme (Roche) | - | - | - | - | [2] 85 85, 229 💬
|
| 449 | Licorice | [1] Licorice Licorice | [1] Glycyrrhiza
Glycyrrhiza
💬
| - | - | [4] 46 46, 53, 74, 224 💬
|
| 450 | Lidocaine | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [14] 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
| 451 | Lidocaine 1% Injectable Solution | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [2] 34 34, 168 💬
|
| 452 | Lidocaine 2% without vessel constrictor | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 51 51 💬
|
| 453 | Lidocaine hydrochloride | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 6 6 💬
|
| 454 | Lidocaine Hydrochloride, Injectable | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 70 70 💬
|
| 455 | Lidocaine Injection 2% | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 168 168 💬
|
| 456 | Lidocaine IV | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 298 298 💬
|
| 457 | Lidocaine patch 5% | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 13 13 💬
|
| 458 | Lidocaine Releasing Intravesical System - LiRIS® | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 226 226 💬
|
| 459 | Light box ( Litebook company) | - | - | - | - | [1] 6 6 💬
|
| 460 | Light box (Litebook company) | - | - | - | - | [1] 6 6 💬
|
| 461 | Ligustrazine | [1] Ligustrazine Ligustrazine | - | - | - | [2] 46 46, 296 💬
|
| 462 | Limaprost | [1] Limaprost Limaprost | [2] Limaprost
Limaprost
,
Limaprost alfadex
💬
| [1] PTGER1 PTGER1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬 | [1] 70 70 💬
|
| 463 | LimphoStat-B | - | - | - | - | [1] 53 53 💬
|
| 464 | Linaclotide | [1] Linaclotide Linaclotide | [2] Linaclotide acetate
Linaclotide acetate
,
Linaclotide
💬
| [1] GUCY2C GUCY2C 💬
| [2] Hormone signaling Hormone signaling, Purine metabolism 💬 | [3] 6 6, 97, 299 💬
|
| 465 | Linaclotide 290 micrograms | [1] Linaclotide Linaclotide | [2] Linaclotide acetate
Linaclotide acetate
,
Linaclotide
💬
| [1] GUCY2C GUCY2C 💬
| [2] Hormone signaling Hormone signaling, Purine metabolism 💬 | [1] 299 299 💬
|
| 466 | Linerixibat | [1] Linerixibat Linerixibat | [1] Linerixibat
Linerixibat
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
| 467 | Linerixibat (GSK2330672) 40 mg | [1] Linerixibat Linerixibat | [1] Linerixibat
Linerixibat
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
| 468 | Linerixibat (GSK2330672) 45 mg | [1] Linerixibat Linerixibat | [1] Linerixibat
Linerixibat
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
| 469 | Linerixibat (GSK2330672) 45mg | [1] Linerixibat Linerixibat | [1] Linerixibat
Linerixibat
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
| 470 | Linez | - | - | - | - | [1] 299 299 💬
|
| 471 | LINEZOLID | [1] Linezolid Linezolid | [1] Linezolid
Linezolid
💬
| - | - | [1] 299 299 💬
|
| 472 | Lingzhi (Ganoderma) | - | - | - | - | [1] 6 6 💬
|
| 473 | Lingzhi and Sen Miao San | - | - | - | - | [1] 46 46 💬
|
| 474 | Linoleic acid | [1] Linoleic acid Linoleic acid | - | - | - | [4] 2 2, 5, 13, 299 💬
|
| 475 | Linoleic acid supplementation | [1] Linoleic acid Linoleic acid | - | - | - | [1] 299 299 💬
|
| 476 | Linoleic Acid/Oleic Acid | [2] Linoleic acid Linoleic acid, Oleic Acid | [1] Oleic acid
Oleic acid
💬
| - | - | [1] 13 13 💬
|
| 477 | Linperlisib | [1] Linperlisib Linperlisib | - | - | - | [2] 61 61, 283 💬
|
| 478 | Linsitinib | [1] Linsitinib Linsitinib | [1] Linsitinib
Linsitinib
💬
| [1] IGF1R IGF1R 💬
| [30] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cadherin signaling, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, Integrin signaling, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 232 232 💬
|
| 479 | Linvoseltamab | [1] Linvoseltamab Linvoseltamab | [1] Linvoseltamab
Linvoseltamab
💬
| [1] TNFRSF17 TNFRSF17 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production 💬 | [1] 28 28 💬
|
| 480 | Liofen XL | - | - | - | - | [1] 13 13 💬
|
| 481 | LIORESAL*50CPR 10MG | - | - | - | - | [1] 2 2 💬
|
| 482 | Liothyronine | [1] Liothyronine Liothyronine | [2] Liothyronine sodium
Liothyronine sodium
,
Liothyronine
💬
| [2] THRA THRA, THRB 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [3] 13 13, 210, 212 💬
|
| 483 | Liothyronine I 131 | [1] Liothyronine Liothyronine | [2] Liothyronine sodium
Liothyronine sodium
,
Liothyronine
💬
| [2] THRA THRA, THRB 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [2] 210 210, 212 💬
|
| 484 | Liothyronine sodium | [1] Liothyronine Liothyronine | [2] Liothyronine sodium
Liothyronine sodium
,
Liothyronine
💬
| [2] THRA THRA, THRB 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 13 13 💬
|
| 485 | LIPASA | - | - | - | - | [1] 299 299 💬
|
| 486 | Lipasa ácida lisosómica, esterasa, colesterol (gen humano LIPA), lipasa ácida lisosómica (gen humano LIPA) | - | - | - | - | [1] 19 19 💬
|
| 487 | LIPASE | - | - | - | - | [2] 298 298, 299 💬
|
| 488 | Lipase CLEC | - | - | - | - | [1] 299 299 💬
|
| 489 | LIPASE LIP2 | - | - | - | - | [1] 299 299 💬
|
| 490 | Lipase Lip2 from Yarrowia lipolytica | - | - | - | - | [1] 299 299 💬
|
| 491 | Lipid Modifying Therapy (LMT) | - | - | - | - | [1] 79 79 💬
|
| 492 | Lipid-lowering agents (Artovastatin) | - | - | - | - | [1] 50 50 💬
|
| 493 | Lipid-lowering treatments | - | - | - | - | [1] 79 79 💬
|
| 494 | Lipid-Modifying Therapy (LMT) | - | - | - | - | [1] 79 79 💬
|
| 495 | Lipiodol® Ultra Fluid with surgical glues | - | - | - | - | [1] 280 280 💬
|
| 496 | Lipitor | - | - | - | - | [4] 51 51, 79, 96, 299 💬
|
| 497 | Lipitor® | - | - | - | - | [2] 46 46, 53 💬
|
| 498 | Lipoic acid | [1] Lipoic acid Lipoic acid | [1] Thioctic acid
Thioctic acid
💬
| - | - | [6] 2 2, 5, 13, 14, 20, 97 💬
|
| 499 | Lipoic acid (LA) with fish oil and LA without fish oil | [2] Fish oil Fish oil, Lipoic acid | [1] Thioctic acid
Thioctic acid
💬
| - | - | [1] 13 13 💬
|
| 500 | Lipoic acid and omega-3 fatty acids | [2] Lipoic acid Lipoic acid, Omega-3 fatty acids | [1] Thioctic acid
Thioctic acid
💬
| - | - | [1] 13 13 💬
|
| 501 | Lipoic acid group | [1] Lipoic acid Lipoic acid | [1] Thioctic acid
Thioctic acid
💬
| - | - | [1] 2 2 💬
|
| 502 | Lipopolysaccharide | - | - | - | - | [1] 6 6 💬
|
| 503 | Liposic | - | - | - | - | [1] 53 53 💬
|
| 504 | Liposomal aerosol cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 505 | Liposomal Amikacin | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 506 | Liposomal Amikacin (Arikace TM) | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 507 | Liposomal Amikacin (Arikace™) | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 508 | Liposomal amikacin for inhalation | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 509 | Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer. | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 510 | Liposomal amphotericin B (Ambisome®) | [1] Amphotericin B Amphotericin B | [1] Amphotericin B
Amphotericin B
💬
| - | - | [1] 299 299 💬
|
| 511 | Liposomal bupivacaine | [1] Bupivacaine Bupivacaine | [2] Bupivacaine hydrochloride
Bupivacaine hydrochloride
,
Bupivacaine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [3] 51 51, 70, 96 💬
|
| 512 | Liposomal Curcumin | [1] Curcumin Curcumin | - | - | - | [1] 97 97 💬
|
| 513 | Liposomal Cyclosporine A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 514 | Liposomal Cyclosporine A 10 mg | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 515 | Liposomal Cyclosporine A 5 mg | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 516 | Liposomal Doxorubicin | [1] Doxorubicin Doxorubicin | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
,
Doxorubicin
💬
| - | - | [1] 331 331 💬
|
| 517 | Liposomal T4N5 lotion | - | - | - | - | [1] 159 159 💬
|
| 518 | Liposome encapsulated BoNT-A | - | - | - | - | [1] 226 226 💬
|
| 519 | Liposomed polyphenols resveratrol and curcumin | [2] Curcumin Curcumin, Resveratrol | - | - | - | [1] 2 2 💬
|
| 520 | Liposomes | - | - | - | - | [1] 226 226 💬
|
| 521 | Lipoxygenase inhibitor | - | - | - | - | [1] 160 160 💬
|
| 522 | Liprotamasa | - | - | - | - | [1] 299 299 💬
|
| 523 | Liprotamase | - | - | - | - | [2] 298 298, 299 💬
|
| 524 | Liprotamase Powder for Oral Solution | - | - | - | - | [1] 299 299 💬
|
| 525 | LIQ861 100 µg | - | - | - | - | [1] 86 86 💬
|
| 526 | LIQ861 106 µg | - | - | - | - | [1] 86 86 💬
|
| 527 | LIQ861 25 µg | - | - | - | - | [1] 86 86 💬
|
| 528 | LIQ861 26.5 µg | - | - | - | - | [1] 86 86 💬
|
| 529 | LIQ861 50 µg | - | - | - | - | [1] 86 86 💬
|
| 530 | LIQ861 53 µg | - | - | - | - | [1] 86 86 💬
|
| 531 | LIQ861 75 µg | - | - | - | - | [1] 86 86 💬
|
| 532 | LIQ861 79.5 µg | - | - | - | - | [1] 86 86 💬
|
| 533 | LIQ861 Inhaled Treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 534 | Liqourice | - | - | - | - | [1] 75 75 💬
|
| 535 | Liquid bubble sampling | - | - | - | - | [1] 162 162 💬
|
| 536 | Liquigen MCT oil | - | - | - | - | [1] 6 6 💬
|
| 537 | Liquorice | - | - | - | - | [1] 83 83 💬
|
| 538 | Liraglutide | [1] Liraglutide Liraglutide | [1] Liraglutide
Liraglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [5] 6 6, 13, 75, 77, 193 💬
|
| 539 | Liraglutide Pen Injector [Saxenda] | [1] Liraglutide Liraglutide | [1] Liraglutide
Liraglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 540 | Lirentelimab | [1] Lirentelimab Lirentelimab | [1] Lirentelimab
Lirentelimab
💬
| - | - | [1] 98 98 💬
|
| 541 | Lirentelimab (AK002) | [1] Lirentelimab Lirentelimab | [1] Lirentelimab
Lirentelimab
💬
| - | - | [1] 98 98 💬
|
| 542 | LiRIS 400 mg | - | - | - | - | [1] 226 226 💬
|
| 543 | LiRIS low dose and LiRIS high dose | - | - | - | - | [1] 226 226 💬
|
| 544 | LiRIS® | - | - | - | - | [1] 226 226 💬
|
| 545 | LiRIS® 400 mg | - | - | - | - | [1] 226 226 💬
|
| 546 | Lisdexamfetamine | [1] Lisdexamfetamine Lisdexamfetamine | [2] Lisdexamfetamine dimesylate
Lisdexamfetamine dimesylate
,
Lisdexamfetamine
💬
| [2] SLC6A2 SLC6A2, SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 547 | Lisdexamfetamine sulfate | [1] Lisdexamfetamine Lisdexamfetamine | [2] Lisdexamfetamine dimesylate
Lisdexamfetamine dimesylate
,
Lisdexamfetamine
💬
| [2] SLC6A2 SLC6A2, SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 548 | Lisinopril | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [9] 19 19, 46, 49, 57, 66, 67, 113, 222, 223 💬
|
| 549 | LISINOPRIL ACTAVIS - 10 MG COMPRESSE 10 COMPRESSE IN BLISTER AL/PVC | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 223 223 💬
|
| 550 | Lisinopril Pills | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 49 49 💬
|
| 551 | Lisinopril, losartan, and atorvastatin | [3] Atorvastatin Atorvastatin, Lisinopril, Losartan | [6] Losartan potassium
Losartan potassium
,
Lisinopril
,
Atorvastatin calcium
,
Atorvastatin
,
Lisinopril
,
Losartan
💬
| [3] ACE ACE, AGTR1, HMGCR 💬
| [22] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 552 | Lisparin | - | - | - | - | [1] 6 6 💬
|
| 553 | Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field | - | - | - | - | [1] 13 13 💬
|
| 554 | LISURIDE | [1] Lisuride Lisuride | [1] Lisuride
Lisuride
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2] 6 6, 86 💬
|
| 555 | Lisuride Hydrogenmaleate | [1] Lisuride Lisuride | [1] Lisuride
Lisuride
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 556 | Lisuride Transdermal System | [1] Lisuride Lisuride | [1] Lisuride
Lisuride
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 557 | Lisuride TTS | [1] Lisuride Lisuride | [1] Lisuride
Lisuride
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 558 | Lisuride TTS 10cm² | [1] Lisuride Lisuride | [1] Lisuride
Lisuride
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 559 | Lisuride TTS 20cm² | [1] Lisuride Lisuride | [1] Lisuride
Lisuride
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 560 | Lithium | - | - | - | - | [5] 2 2, 5, 6, 7, 8 💬
|
| 561 | Lithium Apogepha | - | - | - | - | [1] 2 2 💬
|
| 562 | Lithium aspartate | - | - | - | - | [1] 6 6 💬
|
| 563 | LITHIUM CARBONATE | [1] Lithium carbonate Lithium carbonate | [1] Lithium carbonate
Lithium carbonate
💬
| - | - | [6] 2 2, 13, 17, 18, 127, 310 💬
|
| 564 | Lithium Carbonate 400 MG | [1] Lithium carbonate Lithium carbonate | [1] Lithium carbonate
Lithium carbonate
💬
| - | - | [1] 2 2 💬
|
| 565 | Lithium Carbonate Capsule | [1] Lithium carbonate Lithium carbonate | [1] Lithium carbonate
Lithium carbonate
💬
| - | - | [1] 310 310 💬
|
| 566 | LITHIUM CITRATE | [1] Lithium citrate Lithium citrate | [1] Lithium citrate
Lithium citrate
💬
| - | - | [1] 2 2 💬
|
| 567 | Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug) | - | - | - | - | [1] 307 307 💬
|
| 568 | Lithiumcarbonaat | - | - | - | - | [1] 2 2 💬
|
| 569 | Lithiumcarbonaat 400 PCH tabletten | - | - | - | - | [1] 2 2 💬
|
| 570 | Litifilimab | [1] Litifilimab Litifilimab | [1] Litifilimab
Litifilimab
💬
| - | - | [1] 49 49 💬
|
| 571 | LITIO CARBONATO | - | - | - | - | [3] 2 2, 17, 18 💬
|
| 572 | LIV-GAMMA SN Inj. | - | - | - | - | [1] 63 63 💬
|
| 573 | LIV-GAMMA SN Inj.10% | - | - | - | - | [1] 63 63 💬
|
| 574 | LIV001 | - | - | - | - | [1] 97 97 💬
|
| 575 | Livazo 1 mg film-coated tablets | - | - | - | - | [1] 79 79 💬
|
| 576 | Livazo 1mg film-coated tablets | - | - | - | - | [1] 79 79 💬
|
| 577 | Livazo 2 mg film-coated tablets | - | - | - | - | [1] 79 79 💬
|
| 578 | Livazo 2mg film-coated tablets | - | - | - | - | [1] 79 79 💬
|
| 579 | Livazo 4 mg film-coated tablets | - | - | - | - | [1] 79 79 💬
|
| 580 | Livazo 4mg film-coated tablets | - | - | - | - | [1] 79 79 💬
|
| 581 | Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab | [5] Bacillus subtilis Bacillus subtilis, Bortezomib, Daratumumab, Dexamethasone, Enterococcus faecium | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Bortezomib
,
Dexamethasone phosphate
,
Daratumumab
💬
| [3] CD38 CD38, NR3C1, PSMB5 💬
| [15] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
| 582 | Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules | - | - | - | - | [1] 6 6 💬
|
| 583 | Live Hookworm Larvae | - | - | - | - | [1] 13 13 💬
|
| 584 | Live Necator americanus larvae | - | - | - | - | [1] 13 13 💬
|
| 585 | Live SK08 powder | - | - | - | - | [1] 97 97 💬
|
| 586 | Liver biopsy | - | - | - | - | [3] 171 171, 231, 240 💬
|
| 587 | Liver transplantation | - | - | - | - | [1] 94 94 💬
|
| 588 | Livmarli | - | - | - | - | [2] 297 297, 338 💬
|
| 589 | Livmarli Oral Product | - | - | - | - | [2] 297 297, 338 💬
|
| 590 | Livoletide | [1] Livoletide Livoletide | - | - | - | [1] 193 193 💬
|
| 591 | LIXACOL | - | - | - | - | [1] 97 97 💬
|
| 592 | Lixisenatide | [1] Lixisenatide Lixisenatide | [1] Lixisenatide
Lixisenatide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 593 | Lixivaptan | [1] Lixivaptan Lixivaptan | [1] Lixivaptan
Lixivaptan
💬
| [1] AVPR2 AVPR2 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 594 | LJN452 | - | - | - | - | [1] 93 93 💬
|
| 595 | LJN452, 0,01 mg | - | - | - | - | [1] 93 93 💬
|
| 596 | LJN452, 0,03 mg | - | - | - | - | [1] 93 93 💬
|
| 597 | LJN452, 0,1 mg | - | - | - | - | [1] 93 93 💬
|
| 598 | LJP 394 | - | - | - | - | [1] 49 49 💬
|
| 599 | LJP394 | - | - | - | - | [1] 49 49 💬
|
| 600 | Lloprost(Ventavis,BAYQ6252, 10 µg/mL) | - | - | - | - | [1] 86 86 💬
|
| 601 | Lloprost(Ventavis,BAYQ6252, 20 µg/mL) | - | - | - | - | [1] 86 86 💬
|
| 602 | LM11A-31 | - | - | - | - | [1] 5 5 💬
|
| 603 | LMI070 | - | - | - | - | [2] 3 3, 8 💬
|
| 604 | LMT (atorvastatin, simvastatin, or rosuvastatin) | [3] Atorvastatin Atorvastatin, Rosuvastatin, Simvastatin | [5] Simvastatin
Simvastatin
,
Rosuvastatin calcium
,
Atorvastatin calcium
,
Atorvastatin
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 605 | LMT503 | - | - | - | - | [2] 96 96, 97 💬
|
| 606 | LMTM | - | - | - | - | [1] 127 127 💬
|
| 607 | LMTM/TRx0237 | - | - | - | - | [1] 127 127 💬
|
| 608 | LMWH/Rivaroxaban | [1] Rivaroxaban Rivaroxaban | [1] Rivaroxaban
Rivaroxaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 75 75 💬
|
| 609 | LMX 4 Topical Cream | - | - | - | - | [1] 256 256 💬
|
| 610 | LMY-920 | - | - | - | - | [1] 49 49 💬
|
| 611 | LNG/EE | - | - | - | - | [1] 67 67 💬
|
| 612 | LNK01001 | - | - | - | - | [2] 46 46, 271 💬
|
| 613 | LNK01001 Dose A | - | - | - | - | [1] 46 46 💬
|
| 614 | LNK01001 Dose B | - | - | - | - | [1] 46 46 💬
|
| 615 | LNP023 | - | - | - | - | [7] 61 61, 62, 63, 66, 109, 222, 223 💬
|
| 616 | LNP023 HYDROCHLORI | - | - | - | - | [1] 66 66 💬
|
| 617 | LNP023 hydrochloride | - | - | - | - | [1] 223 223 💬
|
| 618 | LNP023 HYDROCHLORIDE SALT | - | - | - | - | [2] 62 62, 223 💬
|
| 619 | LNP1955 | - | - | - | - | [1] 46 46 💬
|
| 620 | Lo-Ovral Oral Contraceptive Pills | - | - | - | - | [1] 60 60 💬
|
| 621 | LO2A eye drops | - | - | - | - | [1] 53 53 💬
|
| 622 | LO4AB02 | - | - | - | - | [1] 96 96 💬
|
| 623 | LO4AB04 | - | - | - | - | [1] 46 46 💬
|
| 624 | LOBIVON*28CPR 5MG | - | - | - | - | [1] 167 167 💬
|
| 625 | Lobster | [1] Lobster Lobster | - | - | - | [1] 70 70 💬
|
| 626 | Lobster Device | [1] Lobster Lobster | - | - | - | [1] 70 70 💬
|
| 627 | Local Anesthesia (lidocaine hydrochloride) | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 6 6 💬
|
| 628 | Local Trade Name, 2mg | - | - | - | - | [1] 6 6 💬
|
| 629 | Local Trade Name, 4mg | - | - | - | - | [1] 6 6 💬
|
| 630 | Local Trade Name, 8mg | - | - | - | - | [1] 6 6 💬
|
| 631 | Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI) | - | - | - | - | [1] 13 13 💬
|
| 632 | LODALÈS® | - | - | - | - | [1] 6 6 💬
|
| 633 | Lodosyn | - | - | - | - | [1] 13 13 💬
|
| 634 | Lodotra | - | - | - | - | [1] 41 41 💬
|
| 635 | Lodotra (delayed release prednisolone) | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 636 | Lodotra® | - | - | - | - | [1] 46 46 💬
|
| 637 | Loestrin (norethindrone acetate and ethinyl estradiol) | [2] Acetate Acetate, Estradiol | [2] Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 299 299 💬
|
| 638 | Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) | [2] Acetate Acetate, Estradiol | [2] Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [2] 46 46, 49 💬
|
| 639 | Lojuxta 10 mg hard capsules | - | - | - | - | [1] 79 79 💬
|
| 640 | Lojuxta 20 mg hard capsules | - | - | - | - | [1] 79 79 💬
|
| 641 | Lojuxta 5 mg hard capsules | - | - | - | - | [1] 79 79 💬
|
| 642 | Lokomat training | - | - | - | - | [1] 13 13 💬
|
| 643 | Lomecel-B medicinal signaling cells | - | - | - | - | [1] 211 211 💬
|
| 644 | Lomerizine | [1] Lomerizine Lomerizine | - | - | - | [1] 124 124 💬
|
| 645 | LOMITAPIDE | [1] Lomitapide Lomitapide | [2] Lomitapide
Lomitapide
,
Lomitapide mesylate
💬
| [1] MTTP MTTP 💬
| [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 💬
|
| 646 | Lomitapide 2mg hard capsules | [1] Lomitapide Lomitapide | [2] Lomitapide
Lomitapide
,
Lomitapide mesylate
💬
| [1] MTTP MTTP 💬
| [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 💬
|
| 647 | Lonafarnib | [1] Lonafarnib Lonafarnib | [1] Lonafarnib
Lonafarnib
💬
| [2] FNTA FNTA, FNTB 💬
| [1] Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬 | [2] 113 113, 333 💬
|
| 648 | Lonafarnib, Zoledronic Acid, and Pravastatin | [3] Lonafarnib Lonafarnib, Pravastatin, Zoledronic acid | [8] Pravastatin sodium
Pravastatin sodium
,
Zoledronic acid
,
Lonafarnib
,
Zoledronate disodium
,
Zoledronate trisodium
,
Pravastatin
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| [4] FDPS FDPS, FNTA, FNTB, HMGCR 💬
| [5] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [1] 333 333 💬
|
| 649 | Lonapegsomatropin | [1] Lonapegsomatropin Lonapegsomatropin | [1] Lonapegsomatropin
Lonapegsomatropin
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 276 276 💬
|
| 650 | Long term follow up in all patients who received SAR422459 in previous study TDU13583 | [1] SAR422459 SAR422459 | - | - | - | [1] 301 301 💬
|
| 651 | Long Term Follow-Up | - | - | - | - | [1] 169 169 💬
|
| 652 | Long term oxygen therapy | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 88 88 💬
|
| 653 | Long term tapering of prednisolone | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 654 | Long-acting somatostatin | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 67 67 💬
|
| 655 | Long-chain n-3 PUFA | - | - | - | - | [1] 46 46 💬
|
| 656 | Long-circulating liposomal prednisolone | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 657 | Longeveron Mesenchymal Stem Cells | - | - | - | - | [1] 211 211 💬
|
| 658 | Longidaza® | - | - | - | - | [1] 50 50 💬
|
| 659 | Lonodelestat | [1] Lonodelestat Lonodelestat | - | - | - | [1] 299 299 💬
|
| 660 | LONOTEN | - | - | - | - | [1] 179 179 💬
|
| 661 | Lopace | - | - | - | - | [1] 19 19 💬
|
| 662 | Loperamide | [1] Loperamide Loperamide | [2] Loperamide hydrochloride
Loperamide hydrochloride
,
Loperamide
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 13 13, 97 💬
|
| 663 | Loperamide hydrochloride | [1] Loperamide Loperamide | [2] Loperamide hydrochloride
Loperamide hydrochloride
,
Loperamide
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 664 | Lopinavir | [1] Lopinavir Lopinavir | [1] Lopinavir
Lopinavir
💬
| - | - | [1] 265 265 💬
|
| 665 | Lopinavir/Ritonavir | [2] Lopinavir Lopinavir, Ritonavir | [2] Ritonavir
Ritonavir
,
Lopinavir
💬
| - | - | [1] 265 265 💬
|
| 666 | Lopinavir/ritonavir + nevirapine | [3] Lopinavir Lopinavir, Nevirapine, Ritonavir | [3] Ritonavir
Ritonavir
,
Nevirapine
,
Lopinavir
💬
| - | - | [1] 265 265 💬
|
| 667 | Lopinavir/ritonavir + zidovudine + lamivudine | [4] Lamivudine Lamivudine, Lopinavir, Ritonavir, Zidovudine | [4] Lamivudine
Lamivudine
,
Zidovudine
,
Ritonavir
,
Lopinavir
💬
| - | - | [1] 265 265 💬
|
| 668 | Loratadina Stada | [1] Loratadine Loratadine | [1] Loratadine
Loratadine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 89 89 💬
|
| 669 | Loratadina STADA 10 mg | [1] Loratadine Loratadine | [1] Loratadine
Loratadine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 89 89 💬
|
| 670 | Loratadine | [1] Loratadine Loratadine | [1] Loratadine
Loratadine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [5] 13 13, 19, 46, 89, 98 💬
|
| 671 | Lorazepam | [1] Lorazepam Lorazepam | [1] Lorazepam
Lorazepam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 36 36, 231 💬
|
| 672 | Lorcaserin | [1] Lorcaserin Lorcaserin | [2] Lorcaserin hydrochloride
Lorcaserin hydrochloride
,
Lorcaserin hydrochloride hemihydrate
💬
| [1] HTR2C HTR2C 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 140 140 💬
|
| 673 | Lorenzo's Oil | - | - | - | - | [1] 20 20 💬
|
| 674 | LORTAAN*28CPR RIV DIV 50MG | - | - | - | - | [1] 167 167 💬
|
| 675 | Losartan | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [20] 17 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
|
| 676 | Losartan and Atenolol or Propranolol | [3] Atenolol Atenolol, Losartan, Propranolol | [5] Atenolol
Atenolol
,
Losartan potassium
,
Propranolol hydrochloride
,
Losartan
,
Propranolol
💬
| [4] ADRB1 ADRB1, ADRB2, ADRB3, AGTR1 💬
| [25] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 167 167 💬
|
| 677 | Losartan and nebivolol | [2] Losartan Losartan, Nebivolol | [4] Losartan potassium
Losartan potassium
,
Nebivolol
,
Nebivolol hydrochloride
,
Losartan
💬
| [2] ADRB1 ADRB1, AGTR1 💬
| [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 167 167 💬
|
| 678 | Losartan and other angiotensin receptor blockers | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 19 19 💬
|
| 679 | Losartan Bluefish 50 mg | [2] Bluefish Bluefish, Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 680 | Losartan group | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 223 223 💬
|
| 681 | Losartan HEXAL | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 36 36 💬
|
| 682 | LOSARTAN POTASICO | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 179 179 💬
|
| 683 | LOSARTAN POTASSIUM | [2] Losartan Losartan, Potassium | [3] Losartan potassium
Losartan potassium
,
Losartan
,
Potassium
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [5] 36 36, 98, 167, 179, 215 💬
|
| 684 | Losartan potassium 100mg | [2] Losartan Losartan, Potassium | [3] Losartan potassium
Losartan potassium
,
Losartan
,
Potassium
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 223 223 💬
|
| 685 | Losartan potassium 50mg | [2] Losartan Losartan, Potassium | [3] Losartan potassium
Losartan potassium
,
Losartan
,
Potassium
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 223 223 💬
|
| 686 | Losartan Tablets & QingReMoShen Granule | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 687 | Losec | - | - | - | - | [3] 46 46, 225, 294 💬
|
| 688 | Losec Capsules 20 mg | - | - | - | - | [1] 46 46 💬
|
| 689 | LOSMAPIMOD | [1] Losmapimod Losmapimod | [1] Losmapimod
Losmapimod
💬
| [4] MAPK11 MAPK11, MAPK12, MAPK13, MAPK14 💬
| [64] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | [2] 113 113, 222 💬
|
| 690 | LOU064 | [1] Remibrutinib Remibrutinib | [1] Remibrutinib
Remibrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [2] 13 13, 53 💬
|
| 691 | LOU064C1 | - | - | - | - | [1] 13 13 💬
|
| 692 | Lovastatin | [1] Lovastatin Lovastatin | [1] Lovastatin
Lovastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [11] 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
|
| 693 | Lovastatin 60 MG | [1] Lovastatin Lovastatin | [1] Lovastatin
Lovastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 34 34 💬
|
| 694 | Lovastatin ™ | [1] Lovastatin Lovastatin | [1] Lovastatin
Lovastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 34 34 💬
|
| 695 | Lovastatin, then Minocycline/Lovastatin | [2] Lovastatin Lovastatin, Minocycline | [3] Lovastatin
Lovastatin
,
Minocycline hydrochloride
,
Minocycline
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 206 206 💬
|
| 696 | LOVENOX | - | - | - | - | [1] 327 327 💬
|
| 697 | LOVOLDYL*30CPR RIV 5MG | - | - | - | - | [1] 97 97 💬
|
| 698 | Low antigen content diet | - | - | - | - | [1] 66 66 💬
|
| 699 | Low calorie protein substitute | - | - | - | - | [1] 240 240 💬
|
| 700 | Low carbohydrate ketogenic diet | - | - | - | - | [1] 256 256 💬
|
| 701 | Low copper diet | [1] Copper Copper | - | - | - | [1] 171 171 💬
|
| 702 | Low Dietary Sodium | - | - | - | - | [1] 49 49 💬
|
| 703 | Low dose | - | - | - | - | [1] 97 97 💬
|
| 704 | Low dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | [1] 6 6 💬
|
| 705 | Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day | [1] Vitamin D Vitamin D | - | - | - | [1] 13 13 💬
|
| 706 | Low Dose Aspirin (162 mg/day) | - | - | - | - | [1] 13 13 💬
|
| 707 | Low dose BIBF 1120 twice daily | - | - | - | - | [1] 85 85 💬
|
| 708 | Low dose BIBF1120 once daily | - | - | - | - | [1] 85 85 💬
|
| 709 | Low Dose Budesonide | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 710 | Low dose budesonide rectal foam | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 711 | Low dose budesonide tablet | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬
|
| 712 | Low dose cannabis | - | - | - | - | [1] 13 13 💬
|
| 713 | Low dose GR1603 in phase ? | - | - | - | - | [1] 49 49 💬
|
| 714 | Low dose GR1603 in phase ?b | - | - | - | - | [1] 49 49 💬
|
| 715 | Low Dose GT-02287 | - | - | - | - | [1] 6 6 💬
|
| 716 | Low dose levodopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 717 | Low Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | [1] 49 49 💬
|
| 718 | Low Dose MT-1303 | - | - | - | - | [1] 97 97 💬
|
| 719 | Low Dose MYOBLOC (10,000 Units) | - | - | - | - | [1] 13 13 💬
|
| 720 | Low dose naltrexone | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 721 | Low dose of BIIL 284 BS tablets | - | - | - | - | [1] 46 46 💬
|
| 722 | Low dose of MRM-3379 | - | - | - | - | [1] 206 206 💬
|
| 723 | Low dose of MRM-3379 Open-Label | - | - | - | - | [1] 206 206 💬
|
| 724 | Low dose ORTD-1 | - | - | - | - | [1] 46 46 💬
|
| 725 | Low dose prednisolone | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 💬
|
| 726 | Low dose steroids | - | - | - | - | [1] 48 48 💬
|
| 727 | Low dose TSO | - | - | - | - | [1] 96 96 💬
|
| 728 | Low dose vehicle control | - | - | - | - | [1] 46 46 💬
|
| 729 | Low Dose-VIS649 | - | - | - | - | [1] 66 66 💬
|
| 730 | Low energy diode Laser | - | - | - | - | [1] 35 35 💬
|
| 731 | Low fiber diet | - | - | - | - | [1] 96 96 💬
|
| 732 | Low FODMAP | - | - | - | - | [1] 97 97 💬
|
| 733 | Low FODMAP diet | - | - | - | - | [1] 97 97 💬
|
| 734 | Low immunogenic interferon-beta-1a | - | - | - | - | [1] 13 13 💬
|
| 735 | Low molecular weight heparin (enoxeparine) | [1] Heparin Heparin | [2] Heparin sodium
Heparin sodium
,
Heparin calcium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 48 48 💬
|
| 736 | Low Molecular Weight Heparin Calcium Injection | [2] Calcium Calcium, Heparin | [2] Heparin sodium
Heparin sodium
,
Heparin calcium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 224 224 💬
|
| 737 | Low Molecular Weight Heparins (LMWHs) | - | - | - | - | [1] 327 327 💬
|
| 738 | Low Protein and High Fiber Diet | - | - | - | - | [1] 97 97 💬
|
| 739 | Low Residue Diet Intervention | - | - | - | - | [1] 21 21 💬
|
| 740 | Low serine diet | [1] Serine Serine | [1] Serine
Serine
💬
| - | - | [1] 96 96 💬
|
| 741 | Low-dose Aldesleukin (Proleukin®) | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 49 49 💬
|
| 742 | Low-Dose CICR-NAM | - | - | - | - | [1] 97 97 💬
|
| 743 | Low-dose IL-2 | - | - | - | - | [1] 56 56 💬
|
| 744 | Low-dose IL-2 administration | - | - | - | - | [1] 96 96 💬
|
| 745 | Low-dose interleukin-2 | - | - | - | - | [1] 53 53 💬
|
| 746 | Low-dose MH002 | - | - | - | - | [1] 97 97 💬
|
| 747 | Low-dose naltrexone | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬
|
| 748 | Low-Dose Naltrexone (LDN) | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 13 13, 46, 49 💬
|
| 749 | Low-Dose REGN4461 | - | - | - | - | [1] 265 265 💬
|
| 750 | Low-dose rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 751 | Low-Frequency Electromagnetic Resonance Therapy (LF-EMR) | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 752 | Low-Frequency-Only Stimulation | - | - | - | - | [1] 6 6 💬
|
| 753 | Low-molecular-weight heparin | [1] Heparin Heparin | [2] Heparin sodium
Heparin sodium
,
Heparin calcium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 48 48 💬
|
| 754 | Low-volume C1-esterase inhibitor | - | - | - | - | [1] 65 65 💬
|
| 755 | Loxoprofen | [1] Loxoprofen Loxoprofen | [1] Loxoprofen
Loxoprofen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 46 46, 271 💬
|
| 756 | Loxoprofen sodium hydrogel patch | [1] Loxoprofen Loxoprofen | [1] Loxoprofen
Loxoprofen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 757 | Loxoprofen sodium tablet | [1] Loxoprofen Loxoprofen | [1] Loxoprofen
Loxoprofen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 758 | LP-005 Dose 1 (Single) | - | - | - | - | [1] 62 62 💬
|
| 759 | LP-005 Dose 2 (Single) | - | - | - | - | [1] 62 62 💬
|
| 760 | LP-005 Dose 3 (Single) | - | - | - | - | [1] 62 62 💬
|
| 761 | LP-005 Dose 4 (Single) | - | - | - | - | [1] 62 62 💬
|
| 762 | LP-005 Dose 5 (Single) | - | - | - | - | [1] 62 62 💬
|
| 763 | LP-005 Dose 6 (Single) | - | - | - | - | [1] 62 62 💬
|
| 764 | LP-005 Dose 7 (Multiple) | - | - | - | - | [1] 62 62 💬
|
| 765 | LP-005 Dose 8 (Multiple) | - | - | - | - | [1] 62 62 💬
|
| 766 | LP-005 Dose 9 (Multiple) | - | - | - | - | [1] 62 62 💬
|
| 767 | LP-005 Injection | - | - | - | - | [1] 62 62 💬
|
| 768 | LP-08 20mg | - | - | - | - | [1] 226 226 💬
|
| 769 | LP-08 80mg | - | - | - | - | [1] 226 226 💬
|
| 770 | LP-168 tablet | - | - | - | - | [1] 13 13 💬
|
| 771 | LP352 | - | - | - | - | [2] 140 140, 144 💬
|
| 772 | LP352, bexicaserin | [1] Bexicaserin Bexicaserin | [1] Bexicaserin
Bexicaserin
💬
| [1] HTR2C HTR2C 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [2] 140 140, 144 💬
|
| 773 | LPA1 | - | - | - | - | [1] 85 85 💬
|
| 774 | LPM3770164 sustained release tablet | - | - | - | - | [1] 8 8 💬
|
| 775 | LPM3770164 sustained release tablet simulant | - | - | - | - | [1] 8 8 💬
|
| 776 | LPX-TI641 | - | - | - | - | [2] 13 13, 46 💬
|
| 777 | LT-02 | - | - | - | - | [1] 97 97 💬
|
| 778 | LT-02 (modified-release PC pellets) | - | - | - | - | [1] 97 97 💬
|
| 779 | LTI-03 | [1] LTI-03 LTI-03 | - | - | - | [1] 85 85 💬
|
| 780 | LTP | - | - | - | - | [1] 86 86 💬
|
| 781 | LTP001 | - | - | - | - | [2] 85 85, 86 💬
|
| 782 | LTS 0.25mg | - | - | - | - | [1] 46 46 💬
|
| 783 | LTS 0.5mg | - | - | - | - | [1] 46 46 💬
|
| 784 | LTS 1.0mg | - | - | - | - | [1] 46 46 💬
|
| 785 | Lu 00-800 | - | - | - | - | [1] 6 6 💬
|
| 786 | LU 70274 | - | - | - | - | [1] 299 299 💬
|
| 787 | Lu AA24493 | - | - | - | - | [1] 18 18 💬
|
| 788 | Lu AF28996 | - | - | - | - | [1] 6 6 💬
|
| 789 | Lu AF82422 | - | - | - | - | [2] 6 6, 17 💬
|
| 790 | Lu AG06466 | - | - | - | - | [1] 13 13 💬
|
| 791 | Lu AG13909 | - | - | - | - | [2] 75 75, 81 💬
|
| 792 | LUBIPROSTONE | [1] Lubiprostone Lubiprostone | [1] Lubiprostone
Lubiprostone
💬
| [1] CLCN2 CLCN2 💬
| [1] Mineral absorption Mineral absorption 💬 | [5] 6 6, 13, 97, 290, 299 💬
|
| 793 | LUCAR-G79D T cells | - | - | - | - | [1] 49 49 💬
|
| 794 | Lucen | - | - | - | - | [1] 113 113 💬
|
| 795 | Lucentis | - | - | - | - | [1] 166 166 💬
|
| 796 | Lucerastat | [1] Lucerastat Lucerastat | [1] Lucerastat
Lucerastat
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 797 | Lucinactant | [1] Lucinactant Lucinactant | [1] Lucinactant
Lucinactant
💬
| - | - | [1] 299 299 💬
|
| 798 | Lucinactant first | [1] Lucinactant Lucinactant | [1] Lucinactant
Lucinactant
💬
| - | - | [1] 299 299 💬
|
| 799 | Lucrin | - | - | - | - | [1] 67 67 💬
|
| 800 | Lulizumab Pegol | [1] Lulizumab pegol Lulizumab pegol | - | - | - | [1] 49 49 💬
|
| 801 | LUM | - | - | - | - | [1] 299 299 💬
|
| 802 | LUM/IVA | - | - | - | - | [1] 299 299 💬
|
| 803 | LUM/IVA fixed-dose combination | - | - | - | - | [1] 299 299 💬
|
| 804 | LUM001 | - | - | - | - | [4] 93 93, 94, 297, 338 💬
|
| 805 | LUM001 (Maralixibat) | [1] Maralixibat Maralixibat | [2] Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| [2] SLC10A1 SLC10A1, SLC10A2 💬
| [3] Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | [2] 297 297, 338 💬
|
| 806 | LUMACAFTOR | [1] Lumacaftor Lumacaftor | [1] Lumacaftor
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 807 | Lumacaftor / ivacaftor | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 808 | Lumacaftor plus Ivacaftor | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 809 | Lumacaftor Plus Ivacaftor Combination | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 810 | Lumacaftor, Ivacaftor Drug Combination | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 811 | Lumacaftor-ivacaftor | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 812 | Lumacaftor-Ivacaftor treatment | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 813 | Lumacaftor/Ivacaftor | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 814 | Lumacaftor/ivacaftor 100mg/125mg tablets | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 815 | Lumacaftor/ivacaftor 200mg/125mg | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 816 | Lumacaftor/ivacaftor 200mg/125mg tablets | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 817 | Lumacaftor/ivacaftor 200mg/83mg tablet | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 818 | LUMASIRAN | [1] Lumasiran Lumasiran | [2] Lumasiran
Lumasiran
,
Lumasiran sodium
💬
| [1] HAO1 HAO1 💬
| [2] Glyoxylate and dicarboxylate metabolism Glyoxylate and dicarboxylate metabolism, Peroxisome 💬 | [1] 234 234 💬
|
| 819 | Lumason® contrast agent | - | - | - | - | [1] 21 21 💬
|
| 820 | Lumbar epidural injection | - | - | - | - | [1] 70 70 💬
|
| 821 | Lumbar interbody fusion | - | - | - | - | [1] 70 70 💬
|
| 822 | Lumbar Interbody Fusion with Autograft | - | - | - | - | [1] 70 70 💬
|
| 823 | Lumbar Interbody Fusion with NeoFuse | - | - | - | - | [1] 70 70 💬
|
| 824 | Lumbar interlaminar epidural steroid injection | - | - | - | - | [1] 70 70 💬
|
| 825 | Lumbar Punction | - | - | - | - | [1] 8 8 💬
|
| 826 | Lumbar puncture | - | - | - | - | [9] 2 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
|
| 827 | Lumbar puncture and blood withdrawal | - | - | - | - | [1] 13 13 💬
|
| 828 | Lumbar puncture for spinal fluid and blood sample | - | - | - | - | [1] 2 2 💬
|
| 829 | Lumentin 44 | - | - | - | - | [1] 96 96 💬
|
| 830 | Lumiracoxib | [1] Lumiracoxib Lumiracoxib | [1] Lumiracoxib
Lumiracoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 831 | Lumizyme® | - | - | - | - | [1] 256 256 💬
|
| 832 | Lunasin Regimen | - | - | - | - | [1] 2 2 💬
|
| 833 | Lung Clearance Index | - | - | - | - | [1] 299 299 💬
|
| 834 | Lung function measurement | - | - | - | - | [1] 65 65 💬
|
| 835 | Lung Function Testing | - | - | - | - | [1] 340 340 💬
|
| 836 | Lung Spheroid Stem Cells 100 million | - | - | - | - | [1] 85 85 💬
|
| 837 | Lung Spheroid Stem Cells 200 million | - | - | - | - | [1] 85 85 💬
|
| 838 | Lung stem cells | - | - | - | - | [1] 85 85 💬
|
| 839 | Luo-Fu-Shan Plaster | - | - | - | - | [1] 46 46 💬
|
| 840 | Luphere depot 3.75mg(Leuprolide acetate 3.75mg) | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 841 | Lupron (leuprolide acetate) | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 842 | Lupuzor | - | - | - | - | [1] 49 49 💬
|
| 843 | Luspatercept | [1] Luspatercept Luspatercept | [1] Luspatercept
Luspatercept
💬
| [1] ACVR2B ACVR2B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [4] 60 60, 61, 63, 282 💬
|
| 844 | Luspatercept combine with Deferasirox | [2] Deferasirox Deferasirox, Luspatercept | [2] Deferasirox
Deferasirox
,
Luspatercept
💬
| [1] ACVR2B ACVR2B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 60 60 💬
|
| 845 | Lusutrombopag | [1] Lusutrombopag Lusutrombopag | [1] Lusutrombopag
Lusutrombopag
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 846 | Lusutrombopag Oral Tablet | [1] Lusutrombopag Lusutrombopag | [1] Lusutrombopag
Lusutrombopag
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 847 | Lusvertikimab | [1] Lusvertikimab Lusvertikimab | [1] Lusvertikimab
Lusvertikimab
💬
| [1] IL7R IL7R 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, FoxO signaling pathway, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency 💬 | [1] 97 97 💬
|
| 848 | Lutein | [1] Lutein Lutein | - | - | - | [3] 13 13, 90, 164 💬
|
| 849 | Lutein (10 or 30 mg/day) capsules | [1] Lutein Lutein | - | - | - | [1] 90 90 💬
|
| 850 | Lutein plus Zeaxanthin | [2] Lutein Lutein, Zeaxanthin | - | - | - | [1] 164 164 💬
|
| 851 | Luteinizing hormone | [1] Luteinizing hormone Luteinizing hormone | - | - | - | [1] 254 254 💬
|
| 852 | Luteinizing hormone-releasing factor | [1] Luteinizing hormone Luteinizing hormone | - | - | - | [1] 254 254 💬
|
| 853 | LUTENYL | - | - | - | - | [1] 13 13 💬
|
| 854 | Lutikizumab | [1] Lutikizumab Lutikizumab | [1] Lutikizumab
Lutikizumab
💬
| [2] IL1A IL1A, IL1B 💬
| [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [3] 46 46, 96, 97 💬
|
| 855 | Luveris fixed dose | - | - | - | - | [1] 74 74 💬
|
| 856 | Luveris increasing dose | - | - | - | - | [1] 74 74 💬
|
| 857 | Luvometinib | [1] Luvometinib Luvometinib | - | - | - | [1] 34 34 💬
|
| 858 | Luvometinib Tablets | [1] Luvometinib Luvometinib | - | - | - | [1] 34 34 💬
|
| 859 | LVIVO-TaVec400 product | - | - | - | - | [4] 11 11, 13, 49, 300 💬
|
| 860 | LX1606 | - | - | - | - | [1] 97 97 💬
|
| 861 | LX2006 | [1] LX2006 LX2006 | - | - | - | [1] 18 18 💬
|
| 862 | LX3305 | - | - | - | - | [2] 46 46, 161 💬
|
| 863 | LX3305 250 mg capsule | - | - | - | - | [1] 161 161 💬
|
| 864 | LX3305 Dihydrate | - | - | - | - | [1] 46 46 💬
|
| 865 | LX3305 high dose | - | - | - | - | [1] 46 46 💬
|
| 866 | LX3305 low dose | - | - | - | - | [1] 46 46 💬
|
| 867 | LX3305 mid dose | - | - | - | - | [1] 46 46 💬
|
| 868 | LY-M001 Injection | - | - | - | - | [1] 19 19 💬
|
| 869 | LY03003 | - | - | - | - | [1] 6 6 💬
|
| 870 | LY03003 ( Rotigotine, extended-release microspheres) | [1] Rotigotine Rotigotine | [1] Rotigotine
Rotigotine
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 871 | LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection) | [1] Rotigotine Rotigotine | [1] Rotigotine
Rotigotine
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 872 | LY03003( the name of rotigotine) | [1] Rotigotine Rotigotine | [1] Rotigotine
Rotigotine
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 873 | LY03003(Rotigotine,extended-release microspheres) | [1] Rotigotine Rotigotine | [1] Rotigotine
Rotigotine
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 874 | LY03009 F1 | - | - | - | - | [1] 6 6 💬
|
| 875 | LY03009 F2 | - | - | - | - | [1] 6 6 💬
|
| 876 | LY03009 F3 | - | - | - | - | [1] 6 6 💬
|
| 877 | LY03009 F4 | - | - | - | - | [1] 6 6 💬
|
| 878 | LY03017 | - | - | - | - | [1] 6 6 💬
|
| 879 | LY2127399 | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 880 | LY2127399 (Tabalumab) | [1] Tabalumab Tabalumab | [1] Tabalumab
Tabalumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 46 46 💬
|
| 881 | LY2189102 | - | - | - | - | [1] 46 46 💬
|
| 882 | LY2439821 | - | - | - | - | [3] 46 46, 107, 271 💬
|
| 883 | LY248686 | - | - | - | - | [1] 13 13 💬
|
| 884 | LY300164 | - | - | - | - | [1] 6 6 💬
|
| 885 | LY3009104 | - | - | - | - | [10] 46 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
|
| 886 | LY3074828 | - | - | - | - | [2] 96 96, 97 💬
|
| 887 | LY3090106 | - | - | - | - | [1] 53 53 💬
|
| 888 | LY3090106 - IV | - | - | - | - | [1] 46 46 💬
|
| 889 | LY3090106 - SQ | - | - | - | - | [1] 46 46 💬
|
| 890 | LY3154207 | - | - | - | - | [1] 6 6 💬
|
| 891 | LY3337641 | - | - | - | - | [1] 46 46 💬
|
| 892 | LY3337641 20 mg | - | - | - | - | [1] 46 46 💬
|
| 893 | LY3337641 5 mg | - | - | - | - | [1] 46 46 💬
|
| 894 | LY3361237 | - | - | - | - | [2] 49 49, 53 💬
|
| 895 | LY3462817 | - | - | - | - | [1] 46 46 💬
|
| 896 | LY3471851 | - | - | - | - | [2] 49 49, 97 💬
|
| 897 | LY3541860 | - | - | - | - | [2] 13 13, 46 💬
|
| 898 | LY3871801 | - | - | - | - | [1] 46 46 💬
|
| 899 | LY3884961 | [1] LY3884961 LY3884961 | - | - | - | [2] 6 6, 19 💬
|
| 900 | LY3884963 | - | - | - | - | [1] 127 127 💬
|
| 901 | LY3884963 (also referred to as PR006A) | - | - | - | - | [1] 127 127 💬
|
| 902 | LY3962681 | - | - | - | - | [1] 6 6 💬
|
| 903 | LY4006896 | - | - | - | - | [1] 6 6 💬
|
| 904 | LY4213663 | - | - | - | - | [1] 46 46 💬
|
| 905 | LY4256984 | - | - | - | - | [1] 2 2 💬
|
| 906 | LY4268989 | - | - | - | - | [1] 97 97 💬
|
| 907 | LY4298445 | - | - | - | - | [2] 46 46, 49 💬
|
| 908 | LY4395089 | - | - | - | - | [2] 96 96, 97 💬
|
| 909 | LY450190 | - | - | - | - | [1] 86 86 💬
|
| 910 | LYC-30937 | - | - | - | - | [1] 97 97 💬
|
| 911 | LYC-30937-EC | - | - | - | - | [1] 97 97 💬
|
| 912 | Lycium Barbarum | - | - | - | - | [1] 90 90 💬
|
| 913 | Lym-X-Sorb powder | - | - | - | - | [1] 299 299 💬
|
| 914 | Lymph node and blood sampling | - | - | - | - | [1] 296 296 💬
|
| 915 | Lymphocyte immune globulin | - | - | - | - | [1] 96 96 💬
|
| 916 | Lymphodepleting Chemotherapy | - | - | - | - | [3] 49 49, 51, 300 💬
|
| 917 | Lymphodepleting Conditioning | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 918 | Lymphoseek | - | - | - | - | [1] 46 46 💬
|
| 919 | Lymphostat B | - | - | - | - | [1] 63 63 💬
|
| 920 | LymphoStat-B | - | - | - | - | [1] 49 49 💬
|
| 921 | LymphoStat-B (LSB), monoclonal anti-Blys, LSB | - | - | - | - | [1] 49 49 💬
|
| 922 | LymphoStat-B TM | - | - | - | - | [1] 49 49 💬
|
| 923 | LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA® | - | - | - | - | [1] 49 49 💬
|
| 924 | LYNC-101 | - | - | - | - | [1] 97 97 💬
|
| 925 | Lyophilised oral capsules with faecal microbiota | - | - | - | - | [1] 46 46 💬
|
| 926 | Lyophilized etanercept powder(Yisaipu) | [2] Etanercept Etanercept, Yisaipu | [1] Etanercept
Etanercept
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 927 | Lyophilized fecal microbiota (LFMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 928 | Lyrica | - | - | - | - | [1] 298 298 💬
|
| 929 | Lyrica® | - | - | - | - | [1] 298 298 💬
|
| 930 | LYS-GM101 | - | - | - | - | [1] 19 19 💬
|
| 931 | LYS-SAF302 | [1] Olenasufligene relduparvovec Olenasufligene relduparvovec | - | - | - | [1] 19 19 💬
|
| 932 | LYS006 | - | - | - | - | [1] 97 97 💬
|
| 933 | Lysine | [1] Lysine Lysine | [4] Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [4] 13 13, 97, 228, 299 💬
|
| 934 | Lysine-D-Proline-Threonine | [4] D-Proline D-Proline, Lysine, Proline, Threonine | [6] Proline
Proline
,
Threonine
,
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 935 | Lysodase | - | - | - | - | [1] 19 19 💬
|
| 936 | Lysomucil 10 % | - | - | - | - | [1] 299 299 💬
|
| 937 | Lysosomal acid lipase, Esterase cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 19 19 💬
|
| 938 | Lysosomal acid lipase, Esterase, cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 19 19 💬
|
| 939 | LYT-100 | - | - | - | - | [1] 85 85 💬
|
| 940 | LZRSE-Col7A1 Engineered Autologous Epidermal Sheets | - | - | - | - | [1] 36 36 💬
|